 |
|
|
|
| Selected Reading |
 AAP Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2008-2009. (Policy Statement) Pediatrics 2008 (published online Oct 1) [Full text]
AAP Committee on Infectious Diseases. Recommendations for the prevention and treatment of influenza in children, 2009-2010. (Policy Statement) Pediatrics 2009 Oct;24(4) (published online Sep 7) [Full text]
Aballea s, De Juanes JR, Barbieri M, et al. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain. Vaccine 2007 Sep 28;25(39-40):6900-10 [Abstract]
Abed Y, Baz M, Boivin G. A novel neuraminidase deletion conferring resistance to oseltamivir in clinical influenza A/H3N2 virus. J Infect Dis 2009 Jan 15;199(2):180-3 [Abstract]
Abed Y, Goyette N, Boivin G. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob Agents Chemother 2005 Feb;49(2):556-9 [Abstract]
Ablah E, Konda K, Tinius A, et al. Influenza vaccine coverage and presenteeism in Sedgwick County, Kansas. Am J Infect Control 2008 Oct;36(8):588-91 [Abstract]
Abramson JS, Neuzil KM, Tamblyn SE. Annual universal influenza vaccination: ready or not? Clin Infect Dis 2006 Jan 1;42(1):132-5 [Full text]
Adar Y, Singer Y, Levi R, et al. A universal epitope-based influenza vaccine and its efficacy against H5N1. Vaccine 2009 Mar 26;27(15):2099-107 [Abstract]
Alarcon JB, Hartley AW, Harvey NG, et al. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 2007 Apr;14(4):375-81 [Abstract]
Alborzi A, Aelami MH, Ziyaeyan M, et al. Viral etiology of acute respiratory infections among Iranian Hajj pilgrims, 2006. J Travel Med 2009 Jul-Aug;16(4);239-42 [Abstract]
Albright FS, Orlando P, Pavia AT, et al. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008 Jan;197 (published online Dec 11, 2007) [Full text]
Aldridge JR Jr, Moseley CE, Boltz DA, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci 2009 Mar 31;106(13):5306-11 [Abstract]
Ali T, Scott N, Kallas W, et al. Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist). Clin Infect Dis 2004 Mar 1;38(5):760-2 [Abstract]
Alonso WJ, Viboud C, Simonsen L, et al. Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. Am J Epidemiol 2007 (published online Mar 16) [Abstract]
Ambrose CS, Luke C, Coelingh K. Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. Influenza Other Resp Viruses 2008 Dec 8;2(6):193-202 [Full text]
Ambrose CS, Yi TT, Walker RE, et al. Duration of protection provided by live attenuated influenza vaccine in children. Pediatr Infect Dis J 2008 Aug;27(8):744-8 [Abstract]
Amorij JP, Saluja V, Petersen AH, et al. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine 2007 Dec 17;25(52):8707-17 [Abstract]
Anikeeva O, Braunack-Mayer A, Rogers W. Requiring influenza vaccination for health care workers. Am J Public Health 2008 (published online Nov 13) [Abstract]
Ansaldi F, Bacilieri S, Durando P, et al. Cross-protection by MF59(TM)-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses. Vaccine 2008 Mar 17;26(12):1525-9 [Abstract]
APIC (Association for Professionals in Infection Control and Epidemiology). Influenza immunization of healthcare personnel. (Position Paper) Released Oct 9, 2008 [Full text]
Apisarnthanarak A, Puthavathana P, Kitphati R, et al. Outbreaks of influenza A among nonvaccinated healthcare workers: implications for resource-limited settings. Infect Control Hosp Epidemiol 2008;29 (published online Jul 14) [Abstract]
Apisarnthanarak A, Puthavathana P, Mundy LM. Risk factors and outcomes of influenza A (H3N2) pneumonia in an area where avian influenza (H5N1) is endemic. Infect Control Hosp Epidemiol 2007 Apr;28(4):479-82 [Abstract]
Arkema JM, Paget WJ, Meijer A, et al. Seasonal influenza beginning in Europe: report from EISS. Eurosurveillance Weekly 2007 Jan 25;12(1):E070125.3 [Full text]
Arkema JMS, Meijer A, Meerhoff TJ, et al. Epidemiological and virological assessment of influenza activity in Europe, during the 2006-2007 winter. Eurosurveillance Aug 21;13(34):pi=18958 [Full text]
Arnoux S, Weinberger C, Gessner BD. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip--an activated split virion influenza vaccine--supports wider vaccine use. Vaccine 2007 Nov 7;25(45):7720-31 [Abstract]
Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ped Infect Dis J 2006 Oct;15(10):870-9 [Abstract]
Askarian M, Khazaeipour Z, McLaws ML. Influenza vaccination uptake among students and clinical staff of a university in Iran. Int J Infect Dis 2008 (published online Dec 1) [Abstract]
Aspinall R, Del Giudice G, Effros RB, et al. Challenges for vaccination in the elderly. Immun Ageing 2007;4:9 (published online Dec 11) [Abstract]
Atmar RL, Keitel WA, Patel SM, et al. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis 2006 Nov 1;43(9):1135?42 [Abstract]
Aucs P, Buchholz U, Haas W, et al. Influenza associated excess mortality in Germany, 1985-2001. Emerg Themes Epidemiol 2005 Jun 21;2:6 [Full text]
Auewarakul P, Kositanont U, Sornsathapornkul P, et al. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 2007 Jan 8;25(4):659-63 [Abstract]
Babcock HM, Merz LR, Dubberke ER, et al. Case-control study of clinical features of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2008 Oct;19(10):921-6 [Abstract]
Baldo V, Baldovin T, Floreani A, et al. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications. Vaccine 2007 May 16;25(20):3955-61 [Abstract]
Balicer RD, Huerta M, Levy Y, et al. Influenza outbreak control in confined settings. Emerg Infect Dis 2005 Apr;11(4):579-83 [Full text]
Banzhoff A, Pellegrini M, Del Giudice G, et al. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis. Influenza Other Resp Viruses 2008 Dec 8;2(6):243-9 [Full text]
Bardenheier B, Shefer A, McKibben L, et al. Characteristics of long-term care facility residents associated with receipt of influenza and pneumococcal vaccinations. Infect Control Hosp Epidemiol 2004 Dec;25(11):946-54 [Abstract]
Barefoot BE, Sample CJ, Ramsbury EA. A vesicular stomatitis virus recombinant expressing influenza nucleoprotein induces CD8 T cell responses which enhance antibody mediated protection after lethal influenza challenge. Clin Vaccine Immunol 2009 (published online Feb 25) [Abstract]
Basta NE, Halloran ME, Matrajt L, et al. Estimating influenza vaccine efficacy from challenge and community-based study data. Am J Epidemiol 2008 (published online Oct 29) [Abstract]
Bastien N, Bowness D, Burton L, et al. Parotitis in a child infected with triple reassortant influenza A, Canada, 2007. J Clin Microbiol 2009 Jun;47(6):1896-8 [Abstract]
Bauer K, Richter M, Wutzler P, et al. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006. Antiviral Res 2009 Apr;82(1):34-41 [Abstract]
Baumbach JP, Mueller M, Smelser C, et al. Enhancement of influenza surveillance with aggregate rapid influenza test results: New Mexico, 2003-2007. Am J Public Health 2008 (published online Oct 15) [Abstract]
Baz M, Abed Y, McDonald J, et al. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis 2006 Dec 15;43(12):1555-61 [Abstract]
Beckett CG, Kosasih H, Ma'roef C, et al. Influenza surveillance in Indonesia: 1999-2003. Clin Infect Dis 2004 Aug 15;39(4):443-9 [Abstract]
Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 2008 Apr;78(1):91-102 [Abstract]
Belongia EA, Coleman LA, Donahue JG. Effectiveness of influenza vaccination. (Letter) N Engl J Med 2007 Dec 27;357(26):2728-31 [Full text]
Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009 Jan 15;199(2):159-67 [Full text]
Belsche RB. Translational research on vaccines: influenza as an example. Clin Pharmacol Ther 2007 Dec;82(6):745-9 [Abstract]
Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007 Feb 15;256(7):685-96 [Abstract]
Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000 Feb;136(2):168-75 [Abstract]
Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004 Nov 25;351(22):2286-94 [Full text]
Belshe RB, Newman FK, Wilkins K, et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007 Sep 17;25(37-38):6755-63 [Abstract]
Belshe RB, Nichol KL, Black SB, et al. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years. Clin Infect Dis 2004 Oct 1;39(7):920-7 [Abstract]
Benito-Fernandez J, Vazquez-Ronco M, Morteruel-Aizkuren E, et al. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Ped Infect Dis J 2006 Dec;25(12):1153-7 [Abstract]
Beran J, Ambrozaitis A, Laiskonis A, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Medicine 2009 Apr 2;7:13 [Abstract]
Beran J, Wertzova V, Honegr K, et al. Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis 2009 Jan 17;9:2 [Abstract]
Bergen R, Black S, Shinefield H, et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 2004 Feb;23(2):138-44 [Abstract]
Bernard H, Fischer R, Mikolajczyk RT, et al. Nurses' contacts and potential for infectious disease transmission. Emerg Infect Dis 2009 Sep (Epub ahead of print) [Full text]
Besselaar TG, Naidoo D, Buys A, et al. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. (Letter) Emerg Infect Dis 2008 Nov (published online Sep 25) [Full text]
Beutels P, Scuffham PA, MacIntyre CR. Funding of drugs: do vaccines warrant a different approach? (Personal view) Lancet Infect Dis 2008 Nov;8(11):727-33 [Abstract]
Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005 Dec 15;353(24):2559-67 [Abstract]
Bishburg E, Shah M, Mathis AS. Influenza vaccination among medical residents in a teaching hospital. Infect Control Hosp Epidemiol 2008 Jan;29(1):89-91 [Abstract]
Blachere FM, Lindsley WG, Pearce TA, et al. Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis 2009;48 (published online Jan 9) [Abstract]
Blackburne BP, Hay AJ, Goldstein RA. Changing selective pressure during antigenic changes in human influenza H3. PLoS Pathog 2008 May 2;4(5):e1000058 [Full text]
Blank PR, Freiburghaus AU, Schwenkglenks M, et al. Trends in influenza vaccination coverage rates in the United Kingdom over six seasons from 2001-2 to 2006-7. Eurosurveill 2008 Oct 23;13(43):3 [Full text]
Blank PR, Schwenkglenks M, Szucs TD. Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons. Infection 2009 Oct;37(5):390-400 [Abstract]
Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008 Aug 1;8:272 [Abstract - with link to full text]
Bodewes R, Kreijtz JHCM, Rimmelzwaan GF. Yearly influenza vaccinations: a double-edged sword? (Commentary) Lancet Infect Dis 2009 (published online Oct 30) [Abstract]
Bodor M, Montalvo E. Vaccination-related shoulder dysfunction. Vaccine 2007 Jan 8;25(4):585-7 [Abstract]
Booy R, El Bashir H, Rashid H, et al. Influenza and meningococcal disease: lessons for travellers and government from 2 epidemic diseases. Trav Med Infect Dis 2008 (published online Nov 14) [Abstract]
Borlaug G, Newman A, Pfister J, et al. Factors that influenced rates of influenza vaccination among employees of Wisconsin acute care hospitals and nursing homes during the 2005-2006 influenza season. Infect Control Hosp Epidemiol 2007 Dec;28(12):1398-1400 [Abstract]
Bose ME, Littrell JC, Patzer AD, et al. The influenza primer design resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Resp Viruses 2008 Jan;2(1):23-31 [Abstract]
Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses transmit efficiently among guinea pigs by direct contact but not by aerosol. J Virol 2008 Oct;82(20):10052-8 [Abstract]
Bragstad K, Nielsen LP, Fomsgaard A. The evolution of human influenza A viruses from 1999 to 2006 - a complete genome study. Virol J 2008 Mar 7;5(1):40 [Abstract]
Brammer L, Budd A, Cox N. Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Resp Viruses 2009 (published online Feb 12) [Abstract]
Brankston G, Gitterman L, Hirji A, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007, published online Feb 19 [Abstract]
Brett AS, Zuger A. The run on Tamiflu: should physicians prescribe on demand? (Perspective) N Engl J Med 2005 Dec 22;353(24):2636-7 [Full text]
Brewer NT, Hallman WK. Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. Clin Infect Dis 2006 Dec 1;43(11):1379-86 [Abstract]
Bright RA, Carter DM, Daniluk S, et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007 May 10;25(19):3781-8 [Abstract]
Bright RA, Medina M, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005 Oct 1;366(9492):1175-81 [Abstract]
Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006 (published online Feb 2) [Abstract]
Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006 Feb 22;295(8):891-4 [Abstract]
Brooks WA, Terebuh P, Bridges C, et al. Influenza A and B infection in children in urban slum, Bangladesh. (Letter) Emerg Infect Dis 2007 Oct;13(10):1507-8 [Full text]
Brown AS, Begg MD, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004;61(8):774-80 [Abstract]
Brownstein JS, Kleinman KP, Mandl KD. Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. Am J Epidemiol 2005 Oct 1;162(7):686-93 [Abstract]
Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10) [Full text]
Bryant KA, Stover B, Cain L, et al. Improving influenza immunization rates among healthcare workers caring for high-risk pediatric patients. Infect Control Hosp Epidemiol 2004 Dec;25(11):912-7 [Abstract]
Bucher SJ, Brickner PW, Vincent RL. Influenzalike illness among homeless persons. (Letter) Emerg Infect Dis 2006 Jul;12(7) [Full text]
Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci 2007 Jan 2;104(1):246-51 [Abstract]
Bulimo WD, Garner JL, Schnabel DC, et al. Genetic analysis of H3N2 influenza A viruses isolated in 2006-2007 in Nairobi, Kenya. Influenza Other Resp Viruses 2008 (published online Jun 2) [Abstract]
Burbacher TM, Shen DD, Liberato N, et al. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 2005 (published online Apr 21) [Full text]
Burch J, Corbett M, Stock C, et al. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis 2009 Sep;9(9):537-45 [Abstract]
Cabello J, Das K, Trick WE, et al. House staff attitudes about influenza vaccination after participation in a clinical trial to improve vaccination of hospital patients. Infect Control Hosp Epidemiol 2008 Feb (published online Dec 28) [Abstract]
Carpenter LR, Lott J, Lawson BM, et al. Mass distribution of free, intranasally administered influenza vaccine in a public school system. Pediatrics 2007 (published online Jun 25) [Abstract]
Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007 Sep 28;25(39-40):6852-62 [Abstract]
Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008 Apr 1;167(7):775-85 [Full text]
Casscells SW, Granger E, Kress AM, et al. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Circ Cardiovasc Qual Outcomes 2009 Mar;2(2):108-15 [Abstract]
CDC. 2005-06 U.S. influenza season summary. Jul 21, 2006 [Full text]
CDC. 2009-2010 Influenza season triage algorithm for children (< 18 years) with influenza-like illness. Oct 16, 2009 [Chart]
CDC. Antiviral safety information. Nov 3, 2009 (updated regularly) [Full text]
CDC. Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults: Colorado, 2003. MMWR Aug 13;53(31):707-10 [Full text]
CDC. Brief report: Influenza vaccination coverage among children aged 6-23 months--six immunization information system sentinel sites, United States, 2005-06 influenza season. MMWR 2006 Dec 15;55(49):1329-30 [Full text]
CDC. CDC guidance for responses to influenza for institutions of higher education during the 2009-2010 academic year. Aug 20, 2009 [Full text]
CDC. CDC guidance on helping child care and early childhood programs respond to influenza during the 2009-2010 influenza season. Sep 4, 2009 [Full text]
CDC. CDC guidelines for large-scale influenza vaccination clinic planning. May 23, 2007 [Full text]
CDC. CDC guidelines for large-scale influenza vaccination clinic planning: guidelines for the tiered use of inactivated influenza vaccine. May 23, 2007 [Full text]
CDC. CDC recommends against the use of amantadine and rimantadine for the treatment or prophylaxis of influenza in the United States during the 2005-2006 influenza season. CDC Health Alert. Jan 14, 2006 [Full text]
CDC. CDC statement on oseltamivir (Tamiflu) resistance and antiviral recommendations. Jan 9, 2009 [Full text]
CDC. Childhood influenza vaccination coverage--United States, 2004-05 influenza season. MMWR 2006 Oct 6;55(39):1062-5 [Full text]
CDC. Childhood influenza vaccination coverage: United States, 2003-04 influenza season MMWR 2006 Feb 3;55(04):100-3 [Full text]
CDC. Childhood influenza-vaccination coverage: United States, 2002-03 influenza season. MMWR 2004 Sep 24;53(37):863-6 [Full text]
CDC. Composition of the 2005-06 influenza vaccine. Published Apr 18, 2005; updated May 13, 2005 [Full text]
CDC. Destruction of influenza A (H2N2) proficiency testing samples; interim guidance for biosafety level 3-enhanced biocontainment for work with human influenza A (H2N2) viruses. May 3, 2005 [Full text]
CDC. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1)--United States, May-June 2009. MMWR 2009 Nov 13;58(44):1241-5 [Full text]
CDC. Estimated influenza vaccination coverage among adults and children--United States, September 1, 2004-January 31, 2005. MMWR 2005 April 1;54(12):304-7 [Full text]
CDC. Estimates of influenza vaccination target population sizes in 2006 and recent vaccine uptake levels. Jul 17, 2006 [Full text]
CDC. Experiences with influenza-like illness and attitudes regarding influenza prevention: United States, 2003-04 influenza season. MMWR 2004 Dec 17;53(49):1156-8 [Full text]
CDC. Flu vaccine effectiveness: questions and answers for health professionals. Published online Jan 11, 2007 [Full text]
CDC. General questions and answers on thimerosal. Sep 14, 2009 [Full text]
CDC. Guidance for state and local public health officials and school administrators for school (K-12) responses to influenza during the 2009-2010 school year. Aug 7 [Full text]
CDC. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents: United States 2005-06 influenza season. MMWR 2006 Jan 17;55(Dispatch):1-2 [Full text]
CDC. Increased antiviral medication sales before the 2005-06 influenza season: New York City. MMWR 2006 Mar 17;55(10):277-9 [Full text]
CDC. Infection control measures for preventing and controlling influenza transmission in long-term care facilities. Revised Dec 23, 2005 [Full text]
CDC. Influenza activity--United States and worldwide, 2007-08 season. MMWR 2008 Jun 27;57(26):692-97 [Full text]
CDC. Influenza activity--United States and worldwide, May 18-September 19, 2008. MMWR 2008 Sep 26;57(38):1046-9 [Full text]
CDC. Influenza activity: United States and worldwide, 2005-06 season, and composition of the 2006-07 influenza vaccine. MMWR 2006 Jun 16;55(23)648-53 [Full text]
CDC. Influenza activity: United States and worldwide, May 21 - September 9, 2006. MMWR 2006 Sep 22;55(37):1021-3 [Full text]
CDC. Influenza activity: United States and worldwide, May 22 - Sep 3, 2005, and 2005-06 season vaccination recommendations. MMWR 2005 Sep 16;54(36):899-902 [Full text]
CDC. Influenza activity: United States, October 1 - December 9, 2006. MMWR 2006 Dec 22;55(50):1359-62 [Full text]
CDC. Influenza activity: United States, September 30-December 1, 2007. MMWR 2007 Dec 14;56(49):1287-91 [Full text]
CDC. Influenza and pneumococcal vaccination coverage among persons aged >/=65 Years--United States, 2004-2005. MMWR 2006 Oct 6;55(39):1065-8 [Full text]
CDC. Influenza and pneumonococcal vaccination coverage among persons aged >/=65 years with diabetes or asthma: United States, 2003. MMWR 2004 Nov 5;53(43):1007-12 [Full text]
CDC. Influenza antiviral medications: 2005-06 interim chemoprophylaxis and treatment guidelines. Oct 21, 2005 [Web page]
CDC. Influenza round table: warning signs. Released Nov 5, 2009 [Video for consumers]
CDC. Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged >/=65 years: United States, 1991-2002. MMWR 2004 Nov 5;53(43):1012-5 [Full text]
CDC. Influenza vaccination coverage among children aged 16 months - 18 years--eight immunization information system sentinel sites, United States, 2008-2009 influenza season. MMWR 2009 Oct 2;58(38):1059-62 [Full text]
CDC. Influenza vaccination coverage among children aged 6-23 months--United States, 2005-06 influenza season. MMWR 2007 Sep 21;56(37):959-63 [Full text]
CDC. Influenza vaccination coverage among children aged 6-23 Months--United States, 2006-07 influenza season. MMWR 2008 Sep 26;57(38):1039-43 [Full text]
CDC. Influenza vaccination coverage among children aged 6-23 months--United States, 2007-2008 influenza season. MMWR 2009 Oct 2:58(38):1063-6 [Full text]
CDC. Influenza vaccination coverage among children aged 6-59 Months--eight immunization information system sentinel sites, United States, 2007-08 influenza season. MMWR 2008 Sep 26;57(38):1043-6 [Full text]
CDC. Influenza vaccination coverage among children aged 6-59 months--six immunization information system sentinel sites, United States, 2006-07 influenza season. MMWR 2007 Sep 21;56(37):963-5 [Full text]
CDC. Influenza vaccination coverage among children and adults--United States, 2008-09 influenza season. MMWR 2009 Oct 9;58(39):1091-5 [Full text]
CDC. Influenza vaccination coverage among children with asthma--United States, 2004-05 influenza season. MMWR 2007 Mar 9;56(9):193-6 [Full text]
CDC. Influenza vaccination coverage among persons aged 50-64 years enrolled in commercial managed health-care plans. MMWR 2005 Sep 23;54(37):921-3 [Full text]
CDC. Influenza vaccination coverage among persons with asthma--United States, 2005-06 influenza season. MMWR 2008 Jun 20;57(24):653-7 [Full text]
CDC. Influenza vaccination in pregnancy: practices among obstetrician-gynecologists: United States, 2003-04 influenza season. MMWR 2005 Oct 21;54(41):1050-2 [Full text]
CDC. Influenza vaccination levels among persons aged >/=65 years and among persons aged 18-64 years with high-risk conditions: United States, 2003. MMWR 2005 Oct 21;54(41):1045-9 [Full text]
CDC. Influenza vaccine prebooking and distribution strategies for the 2005-06 influenza season. MMWR 2005 April 1;54(12):307-8 [Full text]
CDC. Influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season. MMWR 2005 Sep 2;54(34):850 [Full text]
CDC. Influenza-associated pediatric mortality and Staphylococcus aureus co-infection. (CDC Health Advisory) Jan 30, 2008 [Full text]
CDC. Influenza-associated pediatric mortality and the increase of Staphylococcus aureus co-infection. (CDC Health Advisory) May 9, 2007 [Full text]
CDC. Influenza-testing and antiviral-agent prescribing practices--Connecticut, Minnesota, New Mexico, and New York, 2006-07 influenza season. MMWR 2008 Jan 25;57(3):61-5 [Full text]
CDC. Interim CDC-NIH recommendation for raising the biosafety level for laboratory work involving noncontemporary human influenza (H2N2) viruses. Excerpted from draft: Biosafety in microbiological and biomedical laboratories. Ed 5. May 3, 2005 [Full text]
CDC. Interim guidance for state and local health departments for reporting influenza-associated hospitalizations and deaths for the 2009-2010 season. Sep 8, 2009 [Full text]
CDC. Interim recommendations for clinical use of influenza diagnostic tests during the 2009-10 influenza season. Sep 29, 2009 [Full text]
CDC. Interim recommendations for the use of influenza antiviral medications in the setting of oseltamivir resistance among circulating influenza A (H1N1) viruses, 2008-09 influenza season. Health advisory issued Dec 19, 2008 [Full text]
CDC. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season. MMWR 2008 Apr 18;57(15):393-8 [Full text]
CDC. Interventions to increase influenza vaccination of health-care workers. MMWR 2005 Mar 4;54(8) [Full text]
CDC. Monitoring influenza activity, including 2009 H1N1. (Q&A) Sep 11, 2009 [Full text]
CDC. Notice to readers: Expansion of use of live attenuated influenza vaccine (FluMist) to children aged 2-4 years and other FluMist changes for the 2007-08 influenza season. MMWR Nov 23;56(46):1217-9 [Full text]
CDC. Notice to readers: National Influenza Vaccination Week--November 26-December 2, 2007. MMWR Nov 23;56(46):1216-7 [Full text]
CDC. Preparing for the flu: a communication toolkit for institutions of higher learning. Aug 20, 2009 [Full text]
CDC. Preventing the spread of influenza (the flu) in child care settings: guidance for administrators, care providers, and other staff. Posted Oct 2, 2007 [Full text]
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR 2007 Jun 29;56(Early Release):1-54 [Full text]
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR 2008 Jul 17;57(Early Release):1-60 [Full text]
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006 Jun 28;55(Early release):1-41 [Full text]
CDC. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR 2009 Jul 24;58(Early Release):1-52 [Full text]
CDC. Q&A: Seasonal influenza vaccine supply for the U.S. 2007-08 influenza season. Oct 12, 2007 [Full text]
CDC. Q&A: Thimerosal in seasonal influenza vaccine. Oct 12, 2007 [Full text]
CDC. Questions & answers: Revised recommendations for the use of influenza antiviral drugs. Sep 8, 2009 [Full text]
CDC. Questions & answers: vaccine effectiveness (How well does the influenza or 'flu' vaccine work?). Published online Jan 11, 2007 [Full text]
CDC. Rapid assessment of influenza vaccination coverage among HMO members: northern California influenza seasons, 2001-02 through 2004-05. MMWR 2005 Jul 15;54(27):676-8 [Full text]
CDC. Receipt of influenza vaccine during pregnancy among women With live births--Georgia and Rhode Island, 2004-2007. MMWR 2009 Sep 11;58(35):972-5 [Full text]
CDC. Recommendations for use of antiviral medications for the management of influenza in children and adolescents for the 2009-2010 Season: pediatric supplement for health care providers. Oct 16, 2009 [Full text]
CDC. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 2009 May 22;58(19):521-4 [Full text]
CDC. Severe morbidity and mortality associated with influenza in children and young adults: Michigan, 2003. MMWR 2003:52(35):837-40 [Full text]
CDC. State-specific influenza vaccination coverage among adults aged >/= 18 years--United States, 2003-04 and 2005-06 influenza seasons. MMWR 2007 Sep 21;56(37):953-9 [Full text]
CDC. State-specific influenza vaccination coverage among adults--United States, 2006-07 influenza season. MMWR 2008 Sep 26;57(38):1033-9 [Full text]
CDC. Surveillance for laboratory-confirmed, influenza-associated hospitalizations: Colorado, 2004-05 influenza season. MMWR 2005 Jun 3;54(21):535-7 [Full text]
CDC. Technical report for state and local public health officials and child care and early childhood providers on CDC guidance on helping child care and early childhood programs respond to influenza during the 2009-2010 influenza season. Sep 4, 2009 [Full text]
CDC. Technical report for state and local public health officials and school administrators on CDC guidance for school (K-12) responses to influenza during the 2009-2010 school year. Aug 7, 2009 [Full text]
CDC. Technical report on CDC guidance for responses to influenza for institutions of higher education during the 2009-2010 academic year. Aug 20, 2009 [Full text]
CDC. Tiered use of inactivated influenza vaccine in the event of a vaccine shortage. MMWR 2005 Aug 5;54(30):749-50 [Full text]
CDC. Update: influenza activity--United States and worldwide, 2006-07 season, and composition of the 2007-08 influenza vaccine. MMWR 2007 Aug 10;56(31):789-94 [Full text]
CDC. Update: influenza activity--United States and worldwide, May 20-September 15, 2007. MMWR 2007 Sep 28;56(3):1001-4 [Full text]
CDC. Update: influenza activity--United States, April-August 2009. MMWR 2009 Sep 10;58(Early release):1-4 [Full text]
CDC. Update: influenza activity--United States, August 30-October 31, 2009. MMWR 2009 Nov 13;58(44):1236-41 [Full text]
CDC. Update: influenza activity--United States, October 1, 2006-February 3, 2007. MMWR 2007 Feb 16;56(6):118-21 [Full text]
CDC. Update: influenza activity--United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. MMWR 2009 Apr 17;58(14):369-74 [Full text]
CDC. Update: influenza activity--United States, September 28, 2008-January 31, 2009. MMWR 2009 Feb 13;58(5):115-9 [Full text]
CDC. Update: influenza activity--United States, September 28-November 29, 2008. MMWR 2008 Dec 12;57(49):1329-3 [Full text]
CDC. Update: influenza activity--United States, September 30, 2007-April 5, 2008, and composition of the 2008-09 influenza vaccine. MMWR 2008 Apr 18;57(15):404-9 [Full text]
CDC. Update: influenza activity--United States, September 30, 2007-February 9, 2008. MMWR 2009 Feb 15;57(early release):1-5 [Full text]
CDC. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Sep 8, 2009 [Full text]
CDC. Use of northern hemisphere influenza vaccines by travelers to the southern hemisphere. MMWR 2009 Apr 3;58(12):312 [Full text]
CDC. Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2003 Sep 26:52(RR13):1 [Full text]
CDC. Vaccination coverage among callers to a state influenza hotline: Connecticut, 2004-2005 influenza season. MMWR 2005 Mar 4;54(8) [Full text]
CDC/DHS. Guidance for businesses and employers to plan and respond to the 2009-2010 influenza season. Aug 19, 2009 [Full text]
CDC/NIH. Statement on Simonsen et al article "Impact of influenza vaccination on seasonal mortality in the US elderly population" below. Feb 2005 [Full text]
Chen G-W, Yang C-C, Tsao K-C, et al. Influenza A virus PB1-F2 gene in recent Taiwanese isolates. Emerg Infect Dis 2004 Apr;10 (4):630-8 [Full text]
Chen GW, Shih SR, Hsiao MR, et al. Multiple genotypes of influenza B viruses cocirculated in Taiwan in 2004 and 2005. J Clin Microbiol 2007 May;45(5):1515-22 [Abstract]
Chen J, Deng YM. Influenza viral antigen variation, host antibody production, and new approach to control epidemics. Virol J 2009 Mar 13;6:30 [Abstract]
Chen J, Zhang F, Fang F, et al. Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody. BMC Infect Dis 2007;7:118 (published online Oct 16) [Abstract]
Cheng X, Eisenbraun M, Xu Q, et al. H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines. PLoS ONE 2009 Feb 11;4(2):e4336 [Full text]
Chi RC, Neuzil KM, Lipsky BA, et al. Where high-risk adults receive influenza vaccine during a shortage. Arch Intern Med 2007 Nov 26;167(21):2366-8 [Extract]
Chittaro M, Turello D, Calligaris L, et al. Impact of vaccinating HCWs on the ward and possible influence of avian flu threat. Infection 2009 (published online Jan 13) [Abstract]
Chiu SS, Peiris JSM, Chan KH, et al. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 2007 Jun;119(6):1076-82 [Abstract]
Cho BH, Kolasa MS, Messonnier ML. Influenza vaccination coverage rate among high-risk children during the 2002-2003 influenza season. Am J Infect Control 2008 Oct;36(8):582-7 [Abstract]
Chou CH, Liou WP, Hu KI, et al. Bell's palsy associated with influenza vaccination: two case reports. Vaccine 2007 Apr 12;25(15):2839-41 [Abstract]
Chow A, Ma S, Ling AE, et al. Influenza-associated deaths in tropical Singapore. Emerg Infect Dis 2006 Jan;12(1) [Full text]
Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virology J 2008 Apr 28;5:52 [Abstract]
Christini AB, Shutt KA, Byers KE. Influenza vaccination rates and motivators among healthcare worker groups. Infect Control Hosp Epidemiol 2007 Feb;28(2):171-7 [Abstract]
Chun S, Li C, Domselaar GV, et al. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine 2008 Nov 11;26(48):6068-76 [Abstract]
Clark SJ, Cowan AE, Wortley PM. Influenza vaccination attitudes and practices among US registered nurses. Am J Infect Control 2009 (published online Jun 26) [Abstract]
Coady MH, Galea S, Blaney S, et al. Project VIVA: a multilevel community-based intervention to increase influenza vaccination rates among hard-to-reach populations in New York City. Am J Public Health 2008 Jul;98(7):1314-21 [Abstract]
Coffin SE, Zaoutis TE, Wheeler Rosenquist AB, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 2007 Apr(4);119:740-8 [Abstract]
Cohen NJ, Morita JY, Plate DK, et al. Control of an outbreak due to an adamantane-resistant strain of influenza A (H3N2) in a chronic care facility. Infection 2008 (published online Sep 14) [Abstract]
Cohen S, Alper CM, Doyle WJ, et al. Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza A virus. Psychosom Med 2006 (published online Nov 13) [Abstract]
Coleman MS, Fontanesi J, Meltzer MK, et al. Estimating medical practice expenses from administering adult influenza vaccinations. Vaccine 2005 Jan 4;23(7):915-23 [Abstract]
Colina R, Costa-Mattioli M, Dowling RJO, et al. Translational control of the innate immune response through IRF-7. Nature 2008 Mar 20;452(7185):323-8 (published online Feb 13) [Abstract]
Collin N, de Radigues X, WHO H1N1 Vaccine Task Force. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 2009 Aug 20;27(38):5184-6 [Abstract]
Conti G, Magliani W, Conti S, et al. Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection. Antimicrob Agents Chemother 2008 Dec;52(12):4331-7 [Abstract]
Cooper DL, Smith GE, Regan M, et al. Tracking the spatial diffusion of influenza and norovirus using telehealth data: a spatio-temporal analysis of syndromic data. BMC Med 2008 Jun 26;6:16 [Abstract]
Couch RB, Winokur P, Brady R, et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 2007 Nov 1;25(44):7656-63 [Abstract]
Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households. Ann Intern Med 2009 Oct 6 (published online Aug 4) [Full text]
Cowling BJ, Lau EHY, Lam CLH, et al. Effects of school closures, 2008 winter influenza season, Hong Kong. Emerg Infect Dis 2008 Oct;14(10) (published online Sep 11) [Full text]
Cox NJ, Bridges CB. Inactivated and live attenuated influenza vaccines in young children--how do they compare? (Editorial) N Engl J Med 2007 Feb 15;256(7):729-31 [Abstract]
Crawford LM. FDA's ongoing efforts to ensure the safety, effectiveness, and availability of influenza and other vaccines. Testimony before Senate Special Committee on Aging. Nov 16, 2004 [Full text]
Crepey P, Barthelemy M. Detecting robust patterns in the spread of epidemics: a case study of influenza in the United States and France. Am J Epidemiol 2007 (published online Oct 15) [Abstract]
D'Heilly SJ, Nichol K. Work-site-based influenza vaccination in healthcare and non-healthcare settings. Infect Control Hosp Epidemiol 2004 Dec;25(11):941-5 [Abstract]
Das K, Ma LC, Xiao R, et al. Structural basis for suppression of a host antiviral response by influenza A virus. Proc Natl Acad Sci 2008 (published online Aug 25) [Abstract, with link to free full text]
Daum LT, Shaw M, Klimov AI, et al. Influenza A (H3N2) outbreak, Nepal. Emerg Infect Dis 2005 Aug;11(8) [Full text]
Davila JC, Payne DC, Zhang Y, et al. Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System, 1998-2004. Vaccine 2008 Mar 17;26(12):1577-84 [Abstract]
Dawson ED, Moore CL, Smagala JA, et al. MChip: a tool for influenza surveillance. Anal Chem Nov 15;78(22):7610-5 [Abstract]
de Bruijn I, Meyer I, Gerez L, et al. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly. Vaccine 2007 Dec 21;26(21):119-27 [Abstract]
de Mello WA, de Paiva TM, Ishida MA, et al. The dilemma of influenza vaccine recommendations when applied to the tropics: the Brazilian case examined under alternative scenarios. PLoS ONE 2009 Apr 8;4(4):e5095 [Full text]
Denis J, Acosta-Ramirez E, Zhao Y, et al. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV). Vaccine 2008 Jun 25;26(27-28):3395-403 [Abstract]
Desbiens NA. A 5-year experience with influenza prevention and containment in a program of all-inclusive care for elderly adults. Am J Infect Control 2005 May;33(4):238-42 [Abstract]
DesRoches CM, Blendon RJ, Benson JM. Americans' responses to the 2004 influenza vaccine shortage. Health Affairs 2005 May 24(3):822-31 [Abstract]
Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007 Jul 15;196(2):249-57 [Full text]
Dharan NJ, Gubareva LV, Meyer JJ, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009;301(10) (published online Mar 2) [Full text]
Dharan NJ, Patton M, Siston AM, et al. Outbreak of antiviral drug-resistant influenza A in long-term care facility, Illinois, USA, 2008. Emerg Infect Dis 2009 Dec (Epub ahead of print) [Full text]
Dias A, Bouvier D, Crepin T, et al. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 2009 (published online Feb 4) [Abstract]
Dimmock NJ, Rainsford EW, Scott PD, et al. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol 2008 Sep;82(17):8570-78 [Abstract]
Dodds L, McNeill SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007 Feb 13;176(4):463-8 [Abstract]
Doherty PC, Kelso A. Toward a broadly protective influenza vaccine. (Commentary) J Clin Invest 2008 (published online Sep 18) [Full text]
Dolin R. Influenza: interpandemic as well as pandemic disease. (Perspective) N Engl J Med 2005 Dec 15;353(24):2535-7 [Extract]
Donato AA, Motz LM, Wilson G, et al. Efficacy of multiple influenza vaccine delivery systems in a single facility. Infect Control Hosp Epidemiol 2007 Feb;28(2):219-21 [Abstract]
Doratotaj S, Macknin ML, Worley S. A novel approach to improve influenza vaccination rates among health care professionals: a prospective randomized controlled trial. Am J Infect Control 2008 May;36(4):301-303 [Abstract]
Doshi P. Trends in recorded influenza mortality: United States, 1900-2004. Am J Public Health 2008 (published online Apr 1) [Abstract]
Durando P, Fenoglio D, Boschini A, et al. Safety and immunogenicity of two influenza subunit vaccines, with or without MF59 adjuvant, administered to HIV-1 seropositive and seronegative adults. Clin Vaccine Immunol 2007 (published online Nov 14) [Abstract]
Dushoff J, Plotkin JB, Viboud C, et al. Vaccinating to protect a vulnerable subpopulation. PLoS Med 2007 May;4(5):e174 [Full text]
Duwe S, Schweiger B. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. J Virol Method 2008 (published online Aug 22) [Abstract]
Dwyer DE, Smith DW, Catton MG, et al. Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 2006 Nov 20;185(10 suppl):S48-53 [Full text]
Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005 Nov;5(11):718-25 [Abstract]
ECDC Influenza Project Team. Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update. Eurosurveill 2008 Feb 7;13(6) [Full text]
Eichelberger M, Golding H, Hess M, et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008 Aug 12;26(34):4299-303 [Abstract]
Eick AA, Wang Z, Hughes H, et al. Comparison of the trivalent live attenuated vs inactivated influenza vaccines among US military service members. Vaccine 2009 Jun 2;27(27):3568-75 [Abstract]
Eisenberg KW, Szilagyi PG, Fairbrother G, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008 Nov;122(5):911-9 [Abstract]
El Sahly HM, Keitel WA. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine. Expert Rev Vaccines 2008 Aug;7(6):713-9 [Abstract]
Eliasson DG, Bakkouri KE, Schon K, et al. CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine. Vaccine 2008 Feb 26;26(9);1243-52 [Abstract]
Engler RJM, Nelson MR, Klote MM, et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008 Dec 8/22;168(22):2405-14 [Abstract]
Esposito S, Bosis S, Pelucchi C, et al. Influenza vaccination among healthcare workers in a multidisciplinary University hospital in Italy. BMC Public Health 2008 Dec 23;8:22 [Abstract]
Esposito S, Gasparini C, Martelli A, et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Vaccine 2008 Aug 26;26(36):4664-8 [Abstract]
Esposito S, Tremolati E, Bellasio M, et al. Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children. Vaccine 2007 Jul 20;25(29):5283-9 [Abstract]
Eurosurveillance Editorial Team. Influenza activity in the Southern Hemisphere: a preliminary look at the winter 2007 season. Eurosurveillance Weekly 2007 Aug 23;12(8):E070823.4 [Full text]
Eurosurveillance Editorial team. New WHO influenza vaccine recommendations for 2007-2008 season, northern hemisphere. Eurosurveillance Weekly 2007 Apr 5;12(4):E070405.4 [Full text]
Fabian P, McDevitt JJ, DeHaan WH, et al. Influenza virus in human exhaled breath: an observational study. PLoS ONE 2008 Jul 16;3(7):e2691 [Full text]
Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med 2007;167(4) (published online Jan 22) [Abstract]
Falsey AR, Treanor JJ, Tornieporth N, et al. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009 (published online Jun 9) [Abstract]
Falsey AR. Half-dose influenza vaccine: stretching the supply or wasting it? (Editorial) Arch Intern Med 2008 Dec 8/22;168(22):2402-3 [Extract]
FAO. FAO guidelines for surveillance of pandemic H1N1/2009 and other influenza viruses in swine populations. Aug 11, 2009 [Full text]
Fauci AS. Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 2006 Nov 1;194(suppl 2):S73-6 [Abstract]
FDA. FDA clears first test designed to detect and identify 12 respiratory viruses from single sample. Jan 3, 2008, news release [Full text]
FDA. Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines. May 31, 2007 [Full text]
Fedson DS. Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns. (Editorial Commentary) Clin Infect Dis 2003 Jun 15;36(12):1562-3 [Full text]
Ferko B, Kittel C, Romanova J, et al. Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts. J Virol 2006 Dec;80(23):11621-7 [Abstract]
Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008 Oct;122(4):805-11 [Abstract]
Finkelman BS, Viboud C, Koelle K, et al. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS ONE Dec 12;2(12):e1296 [Full text]
Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Ped Infect Dis J 2006 Oct;15(10):860-9 [Abstract]
Foppa IM, Hossain MM. Revised estimates of influenza-associated excess mortality, United States, 1995 through 2005. Emerg Themes Epidemiol 2008;5(1):26 (published online Dec 30) [Abstract]
France EK, Smith-Ray R, McClure D, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits. Arch Pediatr Adolesc Med 2006 Dec 160(12):1277-83 [Abstract]
Fraser C, Riley S, Anderson RM, et al. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci 2004 Apr 20;101(16):6146-51 [Abstract]
Frech SA, Kenney RT, Spyr CA, et al. Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 2005 Jan 4;23(7):946-50 [Abstract]
Frisbie B, Tang YW, Griffin M, et al. Surveillance of childhood influenza virus infection: what is the best diagnostic method to use for archival samples? J Clin Microbiol 2004 Mar;42(3):1181-4 [Abstract]
Fu TM, Freed DC, Horton MS, et al. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus. Virology 2009 Mar 1;385(1):218-26 [Abstract]
Fujisawa H. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol 2008 Mar;82(6):2772-83 [Abstract]
Fukuda K, Kieny MP. Different approaches to influenza vaccination. N Engl J Med 2006 Dec 14;355(24):2586-7 [Full text]
Furuse Y, Suzuki A, Kamigaki T, et al. Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J Clin Microbiol 2009 Mar 1;47(3):841-4 [Abstract]
Gaglia MA Jr, Cook RL, Kraemer KL, et al. Patient knowledge and attitudes about antiviral medication and vaccination for influenza in an internal medicine clinic. Clin Infect Dis 2007 Nov 1;45(9):1182-8 [Abstract]
Gallagher KM, Juhasz M, Harris NS, et al. Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002. J Infect Dis 2007 Aug 1;196(3):339-46 [Abstract]
Galvani AP, Reluga TC, Chapman GB. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci 2007 (published online Mar 16) [Abstract]
GAO (Government Accountability Office). Federal challenges in responding to influenza outbreaks. Testimony of Janet Heinrich before Special Committee on Aging, US Senate. GAO-04-1100T. Sep 28, 2004 [Full text]
GAO (Government Accountability Office). Flu vaccine: recent supply shortages underscore ongoing challenges. Congressional testimony by Janet Heinrich. GAO-05-177T. Nov 18, 2004 [Full text]
GAO (US Government Accountability Office). Influenza vaccine: issues related to production, distribution, and public health messages. GAO-08-27. Released Nov 16, 2007 (but dated Oct 31) [Full text]
Gao Q, Palese P. Rewiring the RNAs of influenza virus to prevent reassortment. Proc Natl Acad Sci 2009 (published online Sep 8) [Abstract]
Garcia J, Sovero M, Torres AL, et al. Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers. Influenza Other Resp Viruses 2009 Mar;3(2):69-74 [Abstract]
Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E, et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009;339:b3928 (published online Oct 6) [Full text]
Gatrad AR, Shafi S, Memish ZA, et al. Hajj and the risk of influenza (Editorial). BMJ 2006 Dec 9;333(7580):1182-3 [Extract]
Gaydos JC, Top FH Jr, Hodder RA, et al. Swine influenza A outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 2006 Jan;12(1) [Full text]
Gazmararian JA, Coleman M, Prill M, et al. Influenza vaccination of health care workers: policies and practices of hospitals in a community setting. Am J Infect Control 2007 Sep;25(7):441-7 [Abstract]
Ge Q, Filip L, Bai A, et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci 2004 Jun 8;101(23):8676-81 [Abstract]
Gerberding J. Letter to healthcare providers on National Influenza Vaccination Week. Nov 21, 2006 [Full text]
Gerberding JL. Influenza and influenza vaccine safety and supply. Statement before House Committee on Appropriations Subcommittee on Labor, Health and Human Services & Education. Oct 5, 2004 [Full text]
Gerhard W, Mozdzanowska K, Zharikova D. Prospects for universal influenza virus vaccine. Emerg Infect Dis 2006 Apr; 12(4) [Full text]
Gerloff NA, Kremer JR, Mossong J, et al. Genomic diversity of oseltamivir-resistant influenza virus A (H1N1), Luxembourg, 2007-08. (Letter) Emerg Infect Dis 2009 Sep (published online Jul 21) [Full text]
Ghedin E, Fitch A, Boyne A, et al. Mixed infection and the genesis of influenza diversity. J Virol 2009 (published online Jun 24) [Abstract]
Ghedin E, Sengamalay NA, Shumway M, et al. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 2005 Oct 20;437(7062):1162-6 [Abstract]
Ghendon YZ, Markuskin SG, Akopova II, et al. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine. Vaccine 2005 Sep 7;23(38):4678-84 [Abstract]
Ghosh TS, Vogt RL. Active influenza surveillance at the local level: a model for local health agencies. Am J Public Health 2008 Feb;98(2):213-5 [Abstract]
Giezeman KM, Nauta J, de Bruijn IA, et al. Trivalent inactivated subunit influenza vaccine Influvac: 25-year experience of safety and immunogenicity. Vaccine 2009 Apr 21;27(18):2414-7 [Abstract]
Gill TK, Taylor AW, Watson M. Trends in influenza immunisation amongst an elderly Australian community. Vaccine 2007 Jul 20;25(29):5428-32 [Abstract]
Ginsberg J, Mohebbi MH, Patel RS, et al. Detecting influenza epidemics using search engine query data. Nature 2008 (published online Nov 19) [Abstract]
Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18(1):64-76
Glezen WP. Modifying clinical practices to manage influenza in children effectively. Pediatr Infect Dis J 2008 Aug;27(8):738-43 [Abstract]
Glezen WP. Prevention and treatment of seasonal influenza. N Engl J Med 2008 Dec 11;359(24):2579-85 [Full text]
Gocnik M, Fislova F, Mucha V, et al. Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection. J Gen Virol 2008 Apr;89(4):958-67 [Abstract]
Goddard N, Zucs P, Ciancio B, et al. Start of the influenza season 2008-2009 in Europe - increasing influenza activity moving from west to east dominated by A(H3N2). (Rapid communications) Eurosurveill 2009 Jan 22;14(3):pii=19097 [Full text]
Goldstein AO, Kincade JE, Gamble G, et al. Policies and practices for improving influenza immunization rates among healthcare workers. Infect Control Hosp Epidemiol 2004 Dec;25(11):908-11. [Abstract]
Goldstein AO, Kincade JE, Resnick JE, et al. Policies to increase influenza and pneumococcal immunizations in chronically ill and institutionalized settings. Am J Infect Control 2005 Oct;33(8):463-8 [Abstract]
Goodman MJ, Nordin JD, Harper P, et al. The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age. Pediatrics 2006 May;117(5):e821-6 [Abstract]
Gooskens J, Jonges M, Claas ECJ, et al. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. JAMA 2009;301(10) (published online Mar 2) [Full text]
Gooskens J, Jonges M, Claas ECJ, et al. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009 May 15;199(10):1435-41 [Abstract]
Gordon A, Ortega O, Kuan G, et al. Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007. Emerg Infect Dis 2009 Mar (published online Feb 16) [Full text]
Grayson ML, Melvani S, Druce J, et al. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis 2008 (published online Dec 30) [Abstract]
Green MD, Nettey H, Wirtz RA. Determination of oseltamivir quality by colorimetric and liquid chromatographic methods. Emerg Infect Dis 2008 Apr (published online Mar 5) [Full text]
Gregersen JP. A quantitative risk assessment model of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine. Vaccine 2008 Jun 19;26(26):3332-40 [Abstract]
Gregersen JP. A risk-assessment model to rate the occurence and relevance of adventitious agents in the production of influenza vaccines. Vaccine 2008 Jun 19;26(26):3297-304 [Abstract]
Grijalva CG, Craig AS, Dupont WD, et al. Estimating influenza hospitalizations among children. Emerg Infect Dis 2006 Jan;12(1) [Full text]
Grijalva CG, Poehling KA, Edwards KM, et al. Accuracy and interpretation of rapid influenza tests in children. Pediatrics 2007 Jan;119(1):e6-11 [Full text]
Grimm D, Staeheli P, Hufbauer M, et al. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci 2007 (published online Apr 10) [Abstract]
Groth N, Montomoli E, Gentile C, et al. Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential phase I and phase II clinical trial. Vaccine 2009 Jan 29;27(5):786-91 [Abstract]
Guarner J, Paddock CD, Shieh WJ, et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis 2006 Jul 15;43(2):132-40 [Abstract]
Guebre-Xabier M, Hammond SA, Ellingsworth LR, et al. Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice. J Virol 2004 Jul 15;78(14):1610-8 [Abstract]
Gundlapalli AV, Rubin MA, Samore MH, et al. Influenza, winter Olympiad, 2002. Emerg Infect Dis 2005 Jan;12(1) [Full text]
Guo L, Garten RJ, Foust AS, et al. Rapid identification of osteltamivir-resistant influenza A (H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay. Antiviral Res 2009 Apr;82(1):29-33 [Abstract]
Guthrie T, Hobbs CG, Davenport V, et al. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults. J Infect Dis 2004 Dec 1;190(11):1927-35 [Abstract]
Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005 Feb 14;165(3):274-80 [Abstract]
Hak E, Wei F, Nordin J, et al. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004 Feb 1;189(3):450-8 [Abstract]
Hak E. Collaborative efforts are needed to improve use of influenza immunisation in Europe. (Editorial) Eurosurveill 2008 Oct 23;13(43):1 [Full text]
Halasa NB, Gerber MA, Chen Q, et al. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis 2008 (published online Apr 7) [Abstract]
Haldar J, An D, Alvarez de Cienfuegos L, et al. Polymeric coatings that inactivate both influenza virus and pathogenic bacteria. Proc Natl Acad Sci 2006 Nov 21;103(47):17667-71 [Abstract]
Hale BG, Randall RE, Ortin J, et al. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008 Oct;89(10):2359-76 [Abstract]
Hall JS, Bentler KT, Landolt G, et al. Influenza infection in wild raccoons. Emerg Infect Dis 2008 Dec;14(12) (published online Oct 31) [Full text]
Halloran ME, Hayden FG, Yang Y, et al. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol 2007 Jan 15;165(2):212-21 [Abstract]
Halloran ME, Longini IM. Community studies for vaccinating schoolchildren against influenza. Science 2006 Feb 3;311(5761):615-6 [Full text]
Halloran ME, Piedra PA, Longini IM Jr, et al. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine 2007 May 16;25(20):4038-45 [Abstract]
Hambidge SJ, Glanz JM, France EK, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA 2006 Oct 25;296(10):1990-7 [Abstract]
Handel A, Longini IM Jr, Antia R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Comp Biol 2007 Dec 7;3(12):e240 [Full text]
Hao L, Sakurai A, Watanabe T, et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008 Aug 14;454(7206):890-3 [Abstract]
Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009 (published online Mar 12) [Abstract]
Harris A, Cardone G, Winkler DC, et al. Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci 2006 Dec 12;103(50):19123-7 [Abstract]
Harris KM, Maurer J, Lurie N. Is getting influenza vaccine coverage data out during mid-season feasible? Evidence from a national survey of US adults. Vaccine 2009 Jun 8;27(28):3697-9 [Abstract]
Harris KM, Schonlau M, Lurie N. Surveying a nationally representative internet-based panel to obtain timely estimates of influenza vaccination rates. Vaccine 2009 Feb 5;27(5):815-8 [Abstract]
Hassan F, Lewis TC, Davis MM, et al. Hospital utilization and costs among children with influenza, 2003. Am J Preventive Med 2009 Apr;36(4):292-6 [Abstract]
Hatakeyama S, Sugaya N, Ito M, et al. Emergence of influenza B viruses with reduced sensitivity to neuraminidase. JAMA 2007 Apr 4;297(13):1435-42 [Abstract]
Hauge SH, Dudman S, Borgen K, et al. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 2009 Feb (published online Dec 31) [Full text]
Hay AJ, Gregory V, Douglas AR, et al. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 2001 Dec 29;356(1416):1861-70 [Abstract]
Hayden FG, Belshe R, Villanueva C, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 2004 Feb 1;189(3):440-9 [Abstract]
Hayden FG, Pavia AT. Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S119-26 [Abstract]
Haynes JR. Influenza virus-like particle vaccines. Expert Rev Vaccines 2009 Apr;8(4):435-45 [Abstract]
Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006;333 (published online Dec 1) [Abstract]
Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis 2004 Oct 15;190(8):1369-73 [Abstract]
Helms CM, Polgreen PM. Should influenza immunisation be mandatory for healthcare workers? Yes. (Head to Head) BMJ Oct 28;337:a2142 [Extract - also see Isaacs counterpoint below]
Hensley SE, Das SR, Bailey AL, et al. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 2009 Oct 30;326(5953):734-6 [Abstract]
Herlocher ML, Truscon R, Elias S, et al. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 2004 Nov 1;190(9):1627-30 [Abstract]
Heymann A, Chodick G, Reichman B, et al. Influence of school closure on the incidence of viral respiratory diseases among children and on health care utilization. Pediatr Infect Dis J 2004 Jul;23(7):675-7 [Abstract]
Hibbert CL, Piedra PA, McLaurin KK, et al. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine 2007 Nov 19;25(47):8010-20 [Abstract]
Hoa YC, Wang JL, Wang JT, et al. Prognostic factors for fatal adult influenza pneumonia. J Infect 2009 (published online Mar 25) [Abstract]
Holland D, Booy R, De Looze F, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008 (published online Jul 24) [Abstract]
Hollmeyer HG, Hayden F, Poland G, et al. Influenza vaccination of health care workers in hospitals - a review of studies on attitudes and predictors. Vaccine 2009 Jun 19;27(30):3935-44 [Abstract]
Holm MV, Blank PR, Szucs TD. Developments in influenza vaccination coverage in England, Scotland, and Wales covering five consecutive seasons from 2001 to 2006. Vaccine 2007 Nov 14;25(46):7931-8 [Abstract]
Holm MV, Blank PR, Szucs TD. Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006. BMC Infect Dis 2007;7:144 (published online Dec 10) [Abstract]
Holmes EC, Ghedin E, Miller N, et al. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol 2005 Sep;3(9) [Full text]
Holodniy M, Penzak SR, Straight TM, et al. Pharmacokinetics and tolerability of oseltamivir combined with probenecid. Antimicrob Agents Chemother 2008 Sep;52(9):3013-21 [Abstract]
Hota S, McGeer A. Antivirals and the control of influenza outbreaks. Clin Infect Dis 2007 Nov 15;45(10):1362-8 [Abstract]
Hotchkiss JR, Strike DG, Crooke PS. Pathogen transmission and clinic scheduling. Emerg Infect Dis 2005 Jan;12(1) [Full text]
Hourfar MK, Themann A, Eickmann M, et al. Blood screening for influenza. Emerg Infect Dis 2007 Jul;13(7):1081-3 [Full text]
Hubby B, Talarico T, Maughan M, et al. Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine 2007 Nov 23;25(48):8180-9 [Abstract]
Huber VC, McCullers JA. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets. J Infect Dis 2006 Mar 1;193(5):677-84 [Abstract]
Huleatt JW, Nakaar V, Desai P, et al. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 2008 Jan 10;26(2):201-14 [Abstract]
Hull HF, Frauendienst RS, Gundersen ML, et al. School-based influenza immunization. Vaccine 2008 Aug 12;26(34):4312-3 [Abstract]
Hulth A, Rydevik G, Linde A. Web queries as a source for syndromic surveillance. PLoS ONE 2009 Feb 6;4(2):e4378 [Abstract]
Humberd J, Guan Y, Webster RG. Comparison of the replication of influenza A viruses in Chinese ring-necked pheasants and Chukar partridges. J Virol 2006 Mar;80(5):2151-61 [Full text]
Hurt AC, Ernest J, Deng YM, et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, southeast Asia, and South Africa. Antiviral Res 2009 (published online Mar 24) [Abstract]
Hurt AC, Holien JK, Parker M, et al. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol 2009 (published online Jul 29) [Abstract]
IDSA (Infectious Diseases Society of America). Pandemic and seasonal influenza principles for US action. Released Jan 25, 2007 [Full text]
Ilyinskii PO, Gambaryan AS, Merlin AB, et al. Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency. PLoS ONE 2008 Jan 16;3(1):e1417 [Full text]
Ilyushina NA, Govorkova EA, Russell CJ, et al. Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J Gen Virol 2007 Apr;88(4):1266-74 [Abstract]
Influenza team, ECDPC. Influenza transmission: research needs for informing infection control policies and practice. Eurosurveillance Weekly 2007 May 10;12(5):E070510.1 [Full text]
IOM (Institute of Medicine). Immunization safety review: vaccines and autism. Washington, DC: National Academies Press, 2004 [Full text]
Ip M, Tang JW, Hui DSC, et al. Airflow and droplet spreading around oxygen masks: a simulation model for infection control research. Am J Infect Control 2007 Dec;35(10):684-9 [Abstract]
Isaacs D, Leask J. Should influenza immunisation be mandatory for healthcare workers? No. (Head to Head) BMJ Oct 28;337:a2140 [Extract - also see Helms counterpoint above]
Ison MG, Gubareva LV, Atmar RL, et al. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 2006 Mar 15;193(6):760-4 [Abstract]
Ison MG, Mishin V, Braciale TJ, et al. Comparative activities of oseltamivir and A-322278 in immunocompetent and immnocompromised murine models of influenza virus infection. J Infect Dis 2006 Mar 15;193(6):765-72 [Abstract]
Ison MG. Influenza in hospitalized adults: gaining insight into a significant problem. (Editorial commentary) J Infect Dis 2009 (published online Jul 10) [Full text]
Iwane MK, Singleton JA, Walton K, et al. Assessing influenza vaccine utilization in physician offices serving adult patients: experience during a season of vaccine delays and shortages. J Public Health Manag Pract 2007 May/Jun;13(3):307-13 [Abstract]
Iyer SB, Gerber MA, Pomerantz WJ, et al. Effect of point-of-care influenza testing on management of febrile children. Acad Emerg Med 2006 Dec;13(12):1259-68 [Abstract]
Izurieta HS, Haber P, Wise RP, et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 2005 Dec 7;294(21):2720-5 [Abstract]
Jackson LA, Neuzil KM, Baggs J, et al. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study. Pediatrics 2006 Nov;118(5):2032-7 [Abstract]
Jackson LA. Using surveillance to evaluate influenza vaccine effectiveness. (Editorial commentary) J Infect Dis 2009 Jan 15;199(2):155-8 [Full text]
Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008 Aug 2;372(9636):398-405 [Abstract]
Jackson S, Van Hoeven N, Chen LM, et al. Reassortant between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment. J Virol 2009 Aug;83(16):8131-40 [Abstract]
Jafri HS, Ramilo O, Makari D, et al. Diagnostic virology practices for respiratory syncytial virus and influenza virus among children in the hospital setting: a national survey. Ped Infect Dis J 2007 Oct;26(10):956-8 [Abstract]
Jayasekera JP, Moseman EA, Carrol MC. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol 2007 Apr;81(7):3487-94 [Abstract]
Jefferson T, Demicheli V, Rivetti D, et al. Antivirals for influenza in healthy adults: systematic review. Lancet 2006 Jan 28;367(9507):303-13 [Abstract]
Jefferson T, DiPietrantonj C, Debalini MG, et al. Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review. BMJ 2009 Feb 12;338:b354 [Abstract]
Jefferson T, Foxlee R, Del Mar C, et al. Interventions for the interruption or reduction of the spread of respiratory viruses. Cochrane Database Syst Rev 2007 Oct 17;(4):CD006207 [Abstract]
Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005 Oct 1;366(9492):1165-74 [Abstract]
Jefferson T, Smith S, Demicheli V, et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005;365(Feb 26):773-80 [Abstract]
Jefferson T. Influenza vaccination: policy versus evidence. (Analysis and comment) BMJ 2006 Oct 28;333(7574):912-5 [Full text]
Jennings LC, Skopnik H, Burckhardt I, et al. Effect of rapid influenza testing on the clinical management of paediatric influenza. Influenza Other Resp Viruses 2009 May;3(3):91-98 [Abstract]
Jhee SS, Yen M, Ereshefsky L, et al. Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid of healthy Japanese and Caucasian volunteers. Antimicrobial Agents Chemother 2008 Oct;52(10):3687-93 [Abstract]
Jian JW, Chen GW, Lai CT, et al. Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003 to 2006. J Clin Microbiol 2008 Apr;46(4);1426-34 [Abstract]
Jimenez-Garcia R, Carrasco-Garrido P, Hernandez-Barrera V, et al. Estimates of influenza vaccination target population sizes in Spain for the 2006-2007 season. Vaccine 2007 Apr 30;25(17):3249-53 [Abstract]
Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, et al. Influenza vaccination coverages among children, adults, health care workers and immigrants in Spain: related factors and trends, 2003-2006. J Infect 2008 (published online Nov 17) [Abstract]
Jo YM, Song JY, Hwang IS, et al. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. J Med Virol 2009 Feb 23;81(4):722-7 [Abstract]
Johansson BE, Brett IC. Changing perspective on immunization against influenza. Vaccine 2007 Apr 20;25(16):3062-5 [Abstract]
Johnson DF, Druce JD, Birch C, et al. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. (Brief report) Clin Infect Dis 2009 Jul 15;49(2):275-7 [Abstract]
Joint Commission. Providing a safer environment for health care personnel and patients through influenza vaccination: strategies from research and practice. Jun 24, 2009 [Full text]
Jones S, Evans K, McElwaine-John H, et al. DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b trial. Vaccine 2009 Apr 21;27(18):2506-2512 [Abstract]
Jones TF, Ingram LA, Craig AS, et al. Determinants of influenza vaccination, 2003-2004: shortages, fallacies and disparities. Clin Infect Dis 2004 Dec 15;39(12):1824-8 [Abstract]
Jordan R, Olowokure B. Indirect community protection against influenza by vaccinating children: a review of two recent studies from Italy and the United States. Eurosurveillance Weekly 2004 Dec 16;8(51) [Full text]
Juurlink DN, Stukel TA, Kwong J, et al. Guillain-Barre syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 2006 Nov 13;166(20):2217-21 [Abstract]
Katz MA, Tharmaphornpilas P, Chantra S, et al. Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy. Vaccine 2007 May 10;25(19):3827-33 [Abstract]
Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 2006 Aug 15;43(4):439-44 [Full text]
Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. J Infect 2007 (published online Oct 16) [Abstract]
Kawai N, Ikematsu H, Iwaki N, et al. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan on the 2002-2003 influenza season. Clin Infect Dis 2005 May 1;40(9):1309-16 [Abstract]
Kawai N, Ikematsu H, Iwaki N, et al. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. J Infect 2007 Sep;55(3):267-72 [Abstract]
Keech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics 2008;26(11):911-24 [Abstract]
Keitel WA, Atmar RL, Cate TR, et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 2006 May 22;166(10:1121-7 [Abstract]
Keitel WA, Atmar RL, Nino D, et al. Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different variants. J Infect Dis 2008 (published online Aug 25) [Abstract]
Kelly H, Carville K, Grant K, et al. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS ONE 2009 Mar 31;4(3):e5079 [Full text]
Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. (Rapid communications) Eurosurveill 2009 Aug 6;14(31):pii=19288 [Full text]
Kenney RT, Frech SA, Muenz L, et al. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004 Nov 25;351(22):2295-2301 [Full text]
Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005 Nov 2;294(17):2182-7 [Abstract]
Keren R, Zaoutis TE, Saddlemire S, et al. Direct medical cost of influenza-related hospitalizations in children. Pediatrics 2006 Nov;118(5):1321-7 [Abstract]
Khazeni N, Bravata DM, Holty JEC, et al. Safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. Ann Intern Med 2009 Oct 6 (published online Aug 4) [Full text]
Khiabanian H, Farrell GM, St George K, et al. Differences in patient age distribution between influenza A subtypes. PLoS ONE 2009 Aug 31;4(8):e6832 [Full text]
Kilbourne ED. What are the prospects for a universal influenza vaccine? Nat Med 1999 Oct;5(10):1119-20 [Full text]
Kimura AC, Nguyen CN, Higa JI, et al. The effectiveness of vaccine day and educational interventions on influenza vaccine coverage among health care workers at long-term care facilities. Am J Pub Health 2007 Apr;97(4) (published online Feb 28) [Abstract]
King JC Jr, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006 Dec 14;355(24):2523-32 [Full text]
Kiso M, Mitamura K, Sakai-Tagawa Y, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004 Aug 28;364(9436):759-65 [Abstract]
Kochs G, Garcia-Sastre A, Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 2007 Jul;81(13):7011-21 [Abstract]
Koelle K, Cobey S, Grenfell B, et al. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 2006 Dec 22;314(5807):1898-903 [Abstract]
Koerner I, Kochs G, Kalinke U. et al. Protective role of beta interferon in host defense against influenza A virus. J Virol Feb;81(4):2025-30 [Abstract]
Koonin LM, Cetron MS. School closure to reduce influenza transmission. (Letter) Emerg Infect Dis 2009 Jan;15(1):137-9 [Full text]
Kornish LJ, Keeney RL. Repeated commit-or-defer decisions with a deadline: the influenza vaccine composition. Operations Res 2008 May-Jun;56(3):527-41 [Full text]
Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, et al. Transdermal influenza immunization with vaccine coated microneedle arrays. PLoS ONE 2009 Mar 10;4(3):e4773 [Full text]
Kramarz P, Monnet D, Nicoll A, et al. Use of oseltamivir in 12 European countries between 2002 and 2007 - lack of association with the appearance of oseltamivir-resistant influenza A (H1N1) viruses. Eurosurveill 2009 Feb 5;14(5):pii=19112 [Abstract]
Krasnitz M, Levine AJ, Rabadan R. Anomalies in the influenza virus genome database: new biology or laboratory errors? J Virol 2008 Sep;82(17):8947-50 [Abstract]
Kreijtz JH, Bodewes R, van Amerongen G, et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 2007 Jan 8;25(4):612-20 [Abstract]
Kroneman M, Paget WJ, Meuwissen LE, et al. An approach to monitoring influenza vaccination uptake across Europe. Eurosurveillance 2008 May 15;13(20):pii=18874 [Full text]
Kroneman MW, van Essen GA. Stagnating influenza vaccine coverage rates among high-risk groups in Poland and Sweden in 2003/4 and 2004/5. Eurosurveillance Monthly 2007 Apr;12(4) [Full text]
Krumbholz A, Schmidtke M, Bergmann S, et al. High prevalence of amantadine resistance among circulating European porcine influenza A viruses. J Gen Virol 2009 Apr;90(4):900-8 [Abstract]
Kryazhimskiy S, Dieckmann U, Levin SA, et al. On state-space reduction in multi-strain pathogen models, with an application to antigenic drift in influenza A. PLoS Comput Biol 2007 Aug;3(8):e159 [Full text]
Kugel D, Kochs G, Obojes K, et al. Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol 2009 Apr 15;83(8):3843-51 [Abstract]
Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 2008 Sep 12;26(suppl 4):D59-66 [Full text]
Kuntz JL, Holley S, Helms CM, et al. Use of a pandemic preparedness drill to increase rates of influenza vaccination among healthcare workers. Infect Control Hosp Epidemiol 2008 Feb;29(2):111-5 [Abstract]
Kwong JC, Rosella LC, Johansen H. Trends in influenza vaccination in Canada, 1996/1997 to 2005. Health Rep 2007 Nov;18(4) (released Oct 2) [Full text]
Kwong JC, Stukel TA, Lim J, et al. The effect of universal influenza immunization on mortality and health care use. PLoS Med 2008 Oct 28;5(10):e211 [Full text]
La Montagne JR, Fauci AS. Intradermal influenza vaccination--can less be more? (Editorial) N Engl J Med 2004 Nov 25;351(22):2230-2 [Full text]
Lackenby A, Hungnes O, Dudman SG, et al. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Eurosurveillance Weekly 2008 Jan 31;13(5) [Full text]
Lackenby A, Thompson CI, Democratis J. The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis 2008 Dec;21(6):626-38 [Abstract]
Langley JM. Release of the statement on influenza for the 2007-2008 season from the National Advisory Committee on Immunization. CMAJ 2007 Oct 23;177(9):1025-6 [Full text]
Laplante JM, Marshall SA, Shudt M, et al. Influenza antiviral resistance testing in New York and Wisconsin, 2006-2008: methodology and surveillance data. J Clin Microbiol 2009 May;47(5):1372-8 [Abstract]
Lau EHY, Cowling BJ, Ho LM, et al. Optimizing use of multistream influenza sentinel surveillance data. Emerg Infect Dis 2008 Jul (published online Jun 6) [Full text]
LaVela SL, Smith B, Weaver FM, et al. Attitudes and practices regarding influenza vaccination among healthcare workers providing services to individuals with spinal cord injuries and disorders. Infect Control Hosp Epidemiol 2004 Dec;25(11):933-40 [Abstract]
Layne SP. Human influenza surveillance: the demand to expand [Full text]
Lee BY, Mehrotra A, Burns RM, et al. Alternative vaccination locations: who uses them and can they increase flu vaccination rates? (Short communication) Vaccine 2009 Jul 9;27(32):4252-56 [Abstract]
Lee LHW, Ha DLA, Simmons C, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008 (published online Sep 18) [Full text]
Lee MS, Chen JSE. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis 2004 Aug;10(8):1385-90 [Full text]
Lee MS, Chen MC, Liao YC, et al. Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine 2007 Nov 23;25(48):8133-9 [Abstract]
Lee N, Chan PKS, Hui DSC, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009 (published online Jul 10) [Full text]
Lee TH. Rationing influenza vaccine. N Engl J Med 2004 Dec 2;351(23):2365-6 [Extract]
Leekha S, Zitterkopf NL, Espy MJ, et al. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007 Sep;28(9):1071-6 [Abstract]
Lemay R, Mawudeku A, Shi Y, et al. Syndromic surveillance for influenzalike illness. Biosecur Bioterror 2008 Jun;6(2):161-70 [Abstract]
Lemieux C, Brankston G, Gitterman L, et al. Questioning aerosol transmission of influenza. (Letter) Emerg Infect Dis 2007 Jan;13(1) (published online Dec 8) [Full text]
Lenschow DJ, Lai C, Frias-Staheli N, et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci 2007 (published online Jan 16) [Abstract]
Leroux-Roels I, Vets E, Freese R, et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine 2008 Dec 2;26(51):6614-9 [Abstract]
Lessler J, Reich NG, Brookmeyer R, et al. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009 May;9(5):291-300 [Abstract]
Lewis EN, Griffin MR, Szilagyi PG, et al. Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit. Pediatrics 2007 Sep;120(3):467-72 [Abstract]
Li D, Saito R, Le MTQ, et al. Genetic analysis of influenza A/H3N2 and A/H1N1 viruses circulating in Vietnam from 2001 to 2006. J Clin Microbiol 2008 Feb;46(2):399-405 [Abstract]
Li W, Liu Y, Mukhtar MM, et al. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLos ONE 2008 Apr 16;3(4):e1985 [Full text]
Lin JH, Chiu SC, Le CH, et al. Genetic and antigenic analysis of epidemic influenza viruses isolated during 2006-2007 season in Taiwan. J Med Virol 2008 Feb;80(2):316-22 [Abstract]
Lin JH, Tseng CP, Chen YJ, et al. Rapid differentiation of influenza A virus subtypes and genetic screening for virus variants by high-resolution melting analysis. J Clin Microbiol 2008 Mar;46(3):1090-7 [Abstract]
Lindley MC, Groom AV, Wortley PM, et al. Status of influenza and pneumococcal vaccination among older American Indians and Alaska natives. Am J Public Health 2008 (published online Apr 1) [Abstract]
Lipatov AS, Govorkova EA, Webby RJ, et al. Influenza: emergency and control. J Virol 2004 Sep 1;78(17):8951-9 [Link to full text for subscribers]
Liu S, Ji K, Chen J, et al. Panorama phylogenetic diversity and distribution of type A influenza virus. PLoS ONE 2009 Mar 27;4(3):e5022 [Full text]
Loeb M, Dafoe N, Mahony J, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009 (published online Oct 1) [Full text]
Lofgren E, Fefferman NH, Naumov YN, et al. Influenza seasonality: underlying causes and modeling theories. J Virol 2007 Jun;81(11):5429-36 [Abstract]
Long BR, Michaelsson J, Loo CP, et al. Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus. Clin Vaccine Immunol 2008 Jan;15(1):120-30 [Abstract]
Longini IM, Halloran ME. Strategy for distribution of influenza vaccine to high-risk groups and children. (Commentary) Am J Epidemiol 2005 Feb 15;161(4):303-6 [Abstract]
Look JL, Butler B, Al-Khalili M, et al. The adjuvant patch: a universal dose sparing approach for pandemic and conventional vaccines. BioPharm Int 2007 Aug (supp) (published online Aug 2) [Full text]
Lopalco PL, Giesecke. Panel of international experts concludes on influenza and pneumococcal vaccination in Europe. Eurosurveillance Weekly 2007 Jan 18;12(1):E07118.1 [Full text]
Low D. Reducing antibiotic use in influenza: challenges and rewards. Clin Microbiol Infect 2008 Apr;14(4):298-306 [Abstract]
Lowen AC, Mubareka S, Steel J, et al. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 2007 Oct 19;3(10):e151 [Full text]
Lowen AC, Steel J, Mubareka S, et al. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J Virol 2009 Apr;83(7):2803-18 [Abstract]
Lowen AC, Steel J, Mubareka S, et al. High temperature (30 deg C) blocks aerosol but not contact transmission of influenza virus. J Virol 2008 Jun;82(11):5650-2 [Abstract]
Lu B, Zhou H, Ye D, et al. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase acctivities. J Virol 2005 Jun 1;79(11):6763-71 [Abstract]
Lu P, Bridges CB, Euler GL, et al. Influenza vaccination of recommended adult populations, US, 1989-2005. Vaccine 2008 Mar 25;26(14):1786-93 [Abstract]
Lu PJ, Euler GL, Callahan DB. Influenza vaccination among adults with asthma: findings from the 2007 BRFSS survey. Am J Prevent Med 2009 Aug;37(2) (published online Jun 16) [Full text]
Luce BR, Nichol KL, Belshe RB, et al. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Vaccine 2008 June 2;26(33):2841-8 [Abstract]
Lugo NR. Will carrots or sticks raise influenza immunization rates of health care personnel? Am J Infect Control 2007 Feb;35(1):1-6 [Abstract]
Luna LK, Panning M, Grywna K, et al. Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection. J Infect Dis 2007 Mar 1;195(5):675-9 [Abstract]
Ma W, Vincent AL, Gramer MR, et al. Identification of H2N3 influenza A viruses from swine in the United States. Proc Natl Acad Sci 2007 (published online Dec 18) [Abstract]
MacIntyre CR, Cauchemez S, Dwyer DE, et al. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis 2009 Feb;15(2):233 (published online Jan 27) [Full text]
Madjid M, Casscells SW. Of birds and men: cardiologists' role in influenza pandemics. (Letter) Lancet 2004 Oct 9;364(9442):1309 [Full text - Access requires free registration]
Madjid M, Lillibridge S, Mirhaji P, et al. Influenza as a bioweapon. J R Soc Med 2003;96(7):345-6 [Abstract]
Madjid M, Mikller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects. Eur Heart J 2007 (published online Apr 17) [Abstract]
Maeda Y, Hatta M, Takada A, et al. Live bivalent vaccine for parainfluenza and influenza virus infections. J Virol 2005 Jun 1;79(11):6674-9 [Abstract]
Mak TK, Mangtani P, Leese J, et al. Influenza vaccination in pregnancy: Current evidence and selected national policies. Lancet Infect Dis 2008 Jan;8(1):44-52 [Abstract]
Malone JL, Madjid M, Casscells SW. Telephone survey to assess influenza-like illness, United States, 2006. Emerg Infect Dis 2008 Jan;14(1):129-35 (published online Dec 21) [Full text]
Mangtani P, Cumberland P, Hodgson CR, et al. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom General Practice Research Database. J Infect Dis 2004 Jul 1;190(1):1-10 [Abstract]
Mangtani P, Shah A, Roberts JA. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect 2007 Jan;135(1):139-45 [Abstract]
Marsden-Haug N, Foster VB, Gould PL, et al. Code-based syndromic surveillance for influenzalike illness by International Classification of Diseases, Ninth Revision. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 11) [Full text]
Marti F, Steffen R, Mutsch M. Influenza vaccine: a travelers' vaccine. Exp Rev Vaccines 2008 Jul;7(5):679-687 [Abstract]
Matsuzaki Y, Katsushima N, Nagai Y, et al. Clinical features of influenza C virus infection in children. J Infect Dis 2006 May 1;193(9):1229-35 [Abstract]
Maxwell SR. Tamiflu and neuropsychiatric disturbance in adolescents. BMJ 2007 Jun 16;334(7606):1232-3 [Extract]
McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007 Dec 15;45(12):1568-75 [Abstract]
McGeer A, Lee W, Loeb M, et al. Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults. Infect Control Hosp Epidemiol 2004 Dec;25(11):955-61 [Abstract]
McMahon AW, Iskander JK, Haber P, et al. Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. Vaccine 2008 Jan 17;26(3):427-9 [Abstract]
McNeil SA, Noya F, Dionne M, et al. Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults. Vaccine 2007 Apr 30;25(17):3464-74 [Abstract]
McQuillan L, Daley MF, Stokley S, et al. Impact of the 2004-2005 influenza vaccine shortage on pediatric practice: a national survey. Pediatrics 2009 Feb;123(2):e186-92 [Abstract]
Medlock J, Galvani AP. Optimizing influenza vaccine distribution. Science 2009 (published online Aug 20) [Abstract]
Mehlmann, M, Bonner AB, Williams JV, et al. Comparison of the MChip to viral culture, reverse transcription-PCR, and the QuickVue influenza A+B test for rapid diagnosis of influenza. J Clin Microbiol 2007 Apr;45(4):1234-7 [Abstract]
Meijer A, Falcao JM, Jong JC, et al. Clinical influenza activity in Europe is still low, with influenza B virus being dominant: an update from EISS. Eurosurveillance Weekly 2006 Feb 16;11(2) [Full text]
Meijer A, Lackenby A, Hay A, et al. Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season. Eurosurveillance Monthly 2007 Apr;12(4) [Full text]
Meijer A, Lackenby A, Hungnes O, et al. Oseltamivir-resistant influenza A (H1N1) virus, Europe, 2007-08 season. Emerg Infect Dis 2009 Apr (published online Feb 26) [Full text]
Meijer A, Meerhoff TJ, Meuwissen LE, et al. Epidemiological and virological assessment of influenza activity in Europe during the winter 2005-2006. Eurosurveillance Monthly 2007 Sep;12(9):1209-226 [Full text]
Meijer A, Meerhoff TJ, Meuwissen LE, et al. Very little influenza activity in Europe up until the end of 2005. Eurosurveillance Weekly 2006 Jan 6;11(1) [Full text]
Meijer A, Paget WJ, Meerhoff TJ, et al. Epidemiological and virological assessment of influenza activity in Europe, during the 2004-2005 winter. Eurosurveillance Monthly 2006 May;11(5) [Full text]
Meisner J, Szretter KJ, Bradley KC, et al. Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice. J Virol 2008 May;82(10):5079-83 [Abstract]
Melen K, Kinnunen L, Fagerlund R, et al. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol 2007 Jun;81(11):5995-6006 [Abstract]
Melendi GA, Laham FR, Monsalvo AC, et al. Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants. Pediatrics 2007 Aug;120(2):e410-5 [Abstract]
Melidou A, Kyriazopoulou V, Diza E, et al. Antiviral resistance of influenza A(H3N2) strains isolated in Northern Greece between 2004 and 2007. Eurosurveill 2009 Jan 29;14(4):pii=19104 [Full text]
Memoli MJ, Jagger BW, Dugan VG, et al. Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift. J Infect Dis 2009 (published online Sep 10) [Abstract]
Menon B, Gurnani M, Aggarwal B. Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination. Int J Clin Pract 2008 Apr;62(4):593-8 [Abstract]
Mereckiene J, Cotter S, Nicoll A, et al. National seasonal influenza vaccination survey in Europe, 2008. Eurosurveill 2008 Oct 23;13(43):2 [Full text]
Mereckiene J, Cotter S, Weber JT, et al. Low coverage of seasonal influenza vaccination in the elderly in many European countries. Eurosurveill 2008 Oct 9;13(41):1 [Full text]
Meyerholz DK, Edsen-Moore M, McGill J, et al. Chronic alcohol consumption increases the severity of murine influenza virus infections. J Immunol 2008 Jul 1;181(1):641-8 [Abstract]
Mibayashi M, Martinez-Sobrido L, Loo YM, et al. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 2007 Jan;81(2):514-24 [Abstract]
Michiels B, Philips H, Coenen S, et al. The effect of giving influenza vaccination to general practitioners: a controlled trial. BMC Med 2006 Jul 10;4:17 [Abstract]
Miller B, Kassenborg H, Dunsmuir W, et al. Syndromic surveillance for influenzalike illness in ambulatory care setting. Emerg Infect Dis 2004 Oct;10(10):1806-11 [Full text]
Miller EK, Griffin MR, Edwards KM, et al. Influenza burden for children with asthma. Pediatrics 2008 Jan;121(1):1-8 [Abstract]
Mishin VP, Hayden FG, Gubareva LV. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother 2005 Nov;49(11):4515-20 [Abstract]
Mok CK, Lee DC, Cheung CY, et al. Differential onset of apoptosis in influenza A virus H5N1- and H1N1-infected human blood macrophages. J Gen Virol 2007 Apr;88(4):1275-80 [Abstract]
Monto AS, McKimm-Breschkin JL, Macken C, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 2006 Jul 1;50(7):2395-402 [Abstract]
Monto AS, Ohmit SE, Petrie JG, et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009 Sep 24;361(13):1260-7 [Full text]
Monto AS, Ohmit SE. Seasonal influenza vaccines: evolutions and future trends. (Perspective) Expert Rev Vaccines 2009 Apr;8(4):383-9 [Abstract]
Monto AS, Rotthoff J, Teich E, et al. Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis 2004 Aug 15;39(4):459-64 [Abstract]
Monto AS, Whitley RJ. Seasonal and pandemic influenza: a 2007 update on challenges and solutions. Clin Infect Dis 2008;46 (published online Feb 21) [Abstract]
Monto AS. The role of antivirals in the control of influenza. Vaccine 2003 May 1;21(16):1796-800 [Abstract]
Mook P, Ellis J, Watson JM, et al. Public health implication of influenza B outbreaks in closed settings in the United Kingdom in the 2007/08 influenza season. Eurosurveillance 2008 Sep 18;13(38):pii=18986 [Full text]
Moscona A, McKimm-Breschkin J. News about influenza B drug resistance that cannot be ignored. (Editorial) JAMA 2007 Apr 4;297(13):1492-3 [Extract]
Moscona A. Global transmission of oseltamivir-resistant influenza. (Perspective) N Engl J Med 2009 Mar 5;360(10):953-6 [Full text]
Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005 Sep 29;353(13):1363-73 [Extract]
Moscona A. Oseltamivir-resistant influenza? (Commentary) Lancet 2004;364(9436):733-4 [Abstract]
Mubareka S, Palese P. Human genes and influenza. J Infect Dis 2008 Jan;197 (published online Dec 11, 2007) [Full text]
Mubareka SM, Lowen AC, Steel J, et al. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis 2009 (published online Feb 9) [Abstract]
Muller D, Szucs TD. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Infection 2007 (published online Sep 20) [Abstract]
Mullooly JP, Bridges CB, Thompson WW, et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine 2007 Jan 15;25(5):846-55 [Abstract]
Murata Y, Walsh EE, Falsey AR. Pulmonary complications of interpandemic influenza A in hospitalized adults. J Infect Dis 2007 Apr 1;195(7):1029-37 [Abstract]
Mutsch M, Tavernini M, Marx A, et al. Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis 2005 May 1;40(9):1282-7 [Abstract]
Mutsch M, Zhou W, Rhodes P, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004 Feb 26;350(9):896-903 [Abstract]
Nachamkin I, Shadomy SV, Moran AP, et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barre syndrome. J Infect Dis 2008 Jul 15;198(2):226-33 [Abstract]
Nakamura MM, Lee GM. Influenza vaccination in adolescents with high-risk conditions. Pediatrics 2008 Nov;122(5):920-8 [Abstract]
Navas E, Salleras L, Dominguez A, et al. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. Vaccine 2007 Apr 20;25(16):3233-9 [Abstract]
Negri E, Colombo C, Giordano L, et al. Influenza vaccine in healthy children: a meta-analysis. Vaccine 2005 Apr 22;23(22):2851-61 [Abstract]
Neirynck S, Deroo T, Saelens X, et al. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999 Oct;5(10):1157-63 [Abstract]
Nelson MI, Edelman L, Spiro D, et al. Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog 2008 Aug;4(8):e1000133 [Full text]
Nelson MI, Holmes EC. The evolution of epidemic influenza. Nature Rev Genet 2007 Mar;8(3):196-205 [Abstract]
Nelson MI, Simonsen L, Viboud C, et al. Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog 2007 Sep;3(9):e131 [Full text]
Nelson MI, Simonsen L, Viboud C, et al. Stochastic processes are key determinants of short-term evolution in influenza A virus. PLoS Pathogens 2006 Dec;2(12):e125 [Full text]
Nelson MI, Viboud C, Simonsen L, et al. Multiple reassortant events in the evolutionary history of H1N1 influenza A virus since 1918. PLos Pathog 2008 Feb 29;4(2):e1000012 [Full text]
Neuzil KM, Bright RA. Influenza vaccine manufacture: keeping up with change. (Editorial) J Infect Dis 2009 (published online Aug 13) [Full text]
Neuzil KM, Dupont WD, Wright PF, et al. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 2001;20(8):733-40 [Abstract]
Neuzil KM, Jackson LA, Nelson J, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006 Oct 15;194(8):1032-9 [Abstract]
NFID (National Foundation for Infectious Diseases). Improving influenza vaccination rates in health care workers: strategies to increase protection for workers and patients. 2004 [Full text]
Nguyen JT, Hoopes JD, Smee DF, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother 2009 (published online Jul 20) [Abstract]
NICE (UK National Institute for Health and Clinical Excellence). Influenza (prophylaxis): amantadine, oseltamivir and zanamivir. Sep 24, 2008 [Full text of several guidance documents]
Nichol KL, D'Heilly S, Ehlinger E. Colds and influenza-like illnesses in university students: impact on health, academic and work performance, and health care use. Clin Infect Dis 2005 May 1;40(9):1263-70 [Abstract]
Nichol KL, D'Heilly SJ, Greenberg ME, et al. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years. Clin Infect Dis 2008 (published online Dec 30) [Full text]
Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007 Oct 4;357(14):1373-81 [Full text]
Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S111-8 [Abstract]
Nichol KL. Efficacy and effectiveness of influenza vaccination. Vaccine 2008 Sep 12;26(suppl 4):D17-22 [Full text]
Nicholls JM, Bourne AJ, Chen H, et al. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res 2007;8:73 (published online Oct 25) [Abstract]
Nichols WG, Guthrie KA, Corey L, et al. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004 Nov 1;39(9):1300-6 [Abstract]
Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003 Nov 22;362(9397):1733-45 [Abstract]
Nicoll A, Ciancio B, Kramarz on behalf of the Influenza Project Team. Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications. (Editorial) Eurosurveillance Weekly 2008 Jan 31;13(5) [Full text]
Nicoll A, Ciancio BC, Tsolova S, et al. The scientific basis for offering seasonal influenza immunisation to risk groups in Europe. Eurosurveill 2008 Oct 23;13(43):7 [Full text]
Nilsson AC, Alemo B, Bjorkman P, et al. Around-the-clock, rapid diagnosis of influenza by means of membrane chromatography antigen testing confirmed by polymerase chain reaction. Infect Control Hosp Epidemiol 2008;29 (published online Jan 2) [Abstract]
Ninove L, Gazin C, Gould EA, et al. A simple method for molecular detection of swine-origin and human-origin influenza A virus. Vector-Borne Zoonotic Dis 2009 (published online Jun 30) [Full text]
Noda T, Sagara H, Yen A, et al. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature 2006 Jan 26;439(7075):490-2 [Abstract]
Nolan T, Bernstein DI, Block SL, et al. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Pediatrics 2008 Mar;121(3):508-16 [Abstract]
Nowalk MP, Lin CJ, Zimmerman RK, et al. Self-reported influenza vaccination rates among health care workers in a large health system. Am J Infect Control 2008 Oct;36(8):574-81 [Abstract]
Obayashi E, Yoshida H, Kawai F, et al. The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature 2008 (published online Jul 27) [Abstract]
Ofstead CL, Tucker SJ, Beebe TJ, et al. Influenza vaccination among registered nurses: information receipt, knowledge, and decision-making at an institution with a multifaceted educational program. Infect Control Hosp Epidemiol 2008 Feb (published online Dec 28) [Abstract]
Ogata N, Shibata T. Protective effect of low-concentration chlorine dioxide gas against influenza A virus infection. J Gen Virol 2008 Jan;89(1):60-7 [Abstract]
Ohmit SE, Monto AS Symptomatic predictors of influenza virus positivity in children during the influenza season. Clin Infect Dis 2006 Sep 1;43(5):564-8 [Abstract]
Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006 Dec 14;355(24):2513-22 [Full text]
Ohmit SE, Victor JC, Teich ER, et al. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis 2008 Aug 1;198(3):312-7 [Abstract]
Olson DR, Heffernan RT, Paladini M, et al. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Medicine 2007 Aug;4(8):e247 [Full text]
Ong AK, Hayden FG. John F. Enders lecture 2006: antivirals for influenza. J Infect Dis 2007 Jul 15;196(2):181-90 [Abstract]
Opstelten W, van Essen GA, Ballieux MJP, et al. Influenza immunization of Dutch general practitioners: vaccination rate and attitudes towards vaccination. Vaccine 2008 Nov 5;26(47):5918-21 [Abstract]
Ortiz JR, Sotomayor V, Uez OC, et al. Strategy to enhance influenza surveillance worldwide. Emerg Infect Dis 2009 (published online Jun 25) [Full text]
Osterhaus ADME, Poland GA (eds). Influenza vaccines: research, development and public health challenges. Vaccine 2008 Sep 12;26(suppl 4):D1-174 [Abstract]
Otsuka T, Fujinaka H, Katsuyama K, et al. Influenza vaccination for severely multiply handicapped persons/children in the 2005-2006 season. Vaccine 2007 Jun 6;25(23):4521-24 [Abstract]
Ozawa M, Fujii K, Muramoto Y, et al. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol 2007 Jan;81(1):30-41 [Abstract]
Ozawa M, Goto H, Horimoto T, et al. An adenovirus vector-mediated reverse genetics system for influenza A virus generation. J Virol 2007 Sep;81(17):9556-9 [Abstract]
Pabbaraju K, Ho KCY, Wong S, et al. Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007). Antiviral Res 2008 Aug;79(2):81-6 [Abstract]
Paget J, Marquet R, Meijer A, et al. Influenza activity in Europe during eight seasons (1999-2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (aspreada) across Europe. BMC Infect Dis 2007 Nov 30;7:141 [Full text]
Paget WJ, Meijer A, Falcao JM, et al. Seasonal influenza activity for 2005-2006 season seems to be ending in most European countries. Eurosurveillance Weekly 2006 Apr 13;11(4) [Full text]
Palacios G, Quan P-L, Jabado OJ, et al. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis 2007;13(1) (published online Dec 6) [Full text]
Palamara AT, Nencioni L, Aquilano K, et al. Inhibition of influenza A virus replication by resveratrol. J Infect Dis 2005 May 15;191(10):1719-29 [Abstract]
Palese P. Making better influenza virus vaccines. Emerg Infect Dis 2006 Jan;12(1) [Full text]
Paltrinieri S, Spagnolo V, Giordano A, et al. Influenza virus type A serosurvey in cats. (Letter) Emerg Infect Dis 2007 Apr;13(4) (published online Feb 28) [Full text]
Pariani E, Amendola A, Zappa A, et al. Molecular characterization of influenza viruses circulating in Northern Italy during two seasons (2005/2006 and 2006/2007) of low influenza activity. J Med Virol 2008 Nov;80(11):1984-91 (published online Sep 23) [Abstract]
Park AW, Daly JM, Lewis NS, et al. Quantifying the impact of immune escape on transmission dynamics of influenza. Science 2009 Oct 30;326(5953):726-8 [Abstract]
Parkins MD, Fonseca K, Peets AD, et al. A potentially preventable case of serious influenza infection in a pregnant patient. CMAJ 2007 Oct 9;177(8):851-3 [Full text]
Parry MF, Grant B, Iton A, et al. Vaccination: A collaborative effort to improve the health of the community. Infect Control Hosp Epidemiol 2004 Dec;25(11) [Abstract]
Pearson ML, Bridges CB, Harper SA, et al. Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR 2006 Feb 9;55(Early release):1-16 [Full text]
Pechirra P, Goncalves P, Arraiolos A, et al. Characterization of influenza A/Fujian/411/2002(H3N2)-like viruses isolated in Portugal between 2003 and 2005. J Med Virol 2008 Sep;80(9):1624-30 [Abstract]
Peltola V, Reunanen T, Ziegler T, et al. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 2005 Oct 15;41(8):1190-200 [Abstract]
Perez-Ruiz M, Yeste R, Ruiz-Perez MJ, et al. Diagnostic methods for optimal performance testing of influenza in the context of an influenza surveillance network. J Clin Microbiol 2007 Sep;45(9):3109-110 [Abstract]
Petric M, Comanor L, Petti CA. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis 2006 Nov 1;194(suppl 2):S98-110 [Abstract]
Phillips AC, Gallagher S, Carroll D, et al. Preliminary evidence that morning vaccination is associated with an enhanced antibody response in men. Psychophysiology 2008 Jul;45(4):663-6 [Abstract]
Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005 Feb 18;23(13):1540-8 [Abstract]
Piedra PA, Gaglani MJ, Kozinetz CA, et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007 (published online Aug 13) [Abstract]
Podewils LJ, Liedtke LA, McDonald LC, et al. A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin Infect Dis 2005 Jun 1;40(11):1693-6 [Abstract]
Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006 Jul 6;355(1):31-40 [Abstract]
Poland GA, Jacobson RM, Ovsyannikova IG. Influenza virus resistance to antiviral agents: a plea for rational use. (Commentary) Clin Infect Dis 2009 (published online Mar 26) [Abstract]
Poland GA, Ofstead CL, Tucker SJ, et al. Receptivity to mandatory influenza vaccination policies for healthcare workers among registered nurses working on inpatient units. Infect Control Hosp Epidemiol 2008 Feb;29(2):170-3 [Abstract]
Polgreen PM, Chen Y, Pennock DM, et al. Using Internet searches for influenza surveillance. Clin Infect Dis 2008 Dec 1;47(11):1443-8 [Abstract]
Polgreen PM, Nelson FD, Neumann GR. Use of prediction markets to forecast infectious disease activity. Clin Infect Dis 2007 Jan 15;44(2):272-9 [Abstract]
Polgreen PM, Polgreen LA, Evans T, et al. A statewide system for improving influenza vaccination rates in hospital employees. Infect Control Hosp Epidemiol 2009 (published online Mar 27) [Abstract]
Principi N, Esposito S, Gasparini R, et al. Flu-Flu Study Group. Burden of influenza in healthy children and their households. Arch Dis Child 2004 Nov: 89(11):1002-7 [Abstract]
Principi N, Esposito S, Marchisio P, et al. Socioeconomic impact of influenza on healthy children and their families. Pediatr Infect Dis J 2003;22(10 Suppl):S207-10 [Abstract]
Principi N, Esposito S. Are we ready for universal influenza vaccination in paediatrics? Lancet Infect Dis 2004 Feb 1; 4(2):75-83 [Abstract]
Principi N, Esposito S. Pediatric influenza prevention and control. Emerg Infect Dis 2004 Apr;10(4):574-80 [Full text]
Proff R, Gershman K, Lezotte D, et al. Case-based surveillance of influenza hospitalizations during 2004 -2008, Colorado, USA. Emerg Infect Dis 2009 Jun (published online Apr 22) [Full text]
Puig-Barbera J, Diez-Domingo J, Varea AB, et al. Effectiveness of MF59(TM)-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 2007 Oct 16;25(42):7313-21 [Abstract]
Quan FS, Compans RW, Nguyen HH, et al. Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J Virol 2008 Feb;82(3):1350-9 [Abstract]
Quan FS, Steinhauer D, Huang C, et al. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine 2008 Jun 19;26(26):3352-51 [Abstract]
Quan FS, Yoo DG, Song JM, et al. Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination. J Virol 2009 May;83(9):4489-97 [Abstract]
Quan PL, Palacios G, Jabado OJ, et al. Detection of respiratory viruses and subtype identification of influenza A viruses by GreeneChipResp oligonucleotide microarray. J Clin Microbiol 2007 Aug;45(8):2359-64 [Abstract]
Radonovich LJ Jr, Bender BS, Small PA Jr. Children should be among the highest priority groups to receive immunization for seasonal and pandemic influenza. (Letter) Biosecur Bioterror 2007 Dec;5(4):363-6 [Extract]
Rahman M, Bright RA, Kieke BA, et al. Adamantane-resistant influenza infection during the 2004-05 season. Emerg Infect Dis 2008 Jan;14(1):173-6 (published online Dec 21) [Full text]
Rambaut A, Pybus OG, Nelson MI, et al. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008 May 29;453(7195):615-9 [Abstract]
Rameix-Welti MA, Enouf V, Cuvelier F, et al. Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog 2008 Jul 25;4(7):e1000103 [Full text]
Ramet J, Weil-Oliver C, Sedlak W. Influenza vaccination: the pediatric perspective. Vaccine 2007 Jan 15;25(5):780-7 [Abstract]
Ramirez A, Capuano AW, Wellman DA, et al. Preventing zoonotic influenza virus infection. Emerg Infect Dis 2006 Jun;12(6):997-1000 [Full text]
Rashid H, Shafi S, Haworth E, et al. Influenza vaccine in Hajj pilgrims: policy issues from field studies. Vaccine 2008 Sep 2;26(37):4809-12 [Abstract]
Rashid H, Shafi S, Haworth E, et al. Value of rapid testing for influenza among Hajj pilgrims. Travel Med Infect Dis 2007 (published online Sep 10) [Abstract]
Rashid H, Shafi S, Haworth E, et al. Viral respiratory infections at the Hajj: comparison between UK and Saudi pilgrims. Clin Microbiol Infect 2008 Jun;14(6):569-74 (published online Mar 28) [Abstract]
Recker M, Pybus OG, Nee S, et al. The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types. Proc Natl Acad Sci 2007 May 1;104(18):7711-6 (published online Apr 25) [Abstract]
Redlberger M, Aberle SW, Heinz FX, et al. Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria. Vaccine 2007 Aug 10;25(32):6061-9 [Abstract]
Reisinger KS, Block SL, Izu A, et al. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity. J Infect Dis 2009 (published online Aug 12) [Abstract]
Rhorer J, Ambrose CS, Dickinson S, et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine 2009 Feb 11;27(7):1101-10 [Abstract]
Ribner BS, Hall C, Steinberg JP, et al. Use of a mandatory declination form in a program for influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol 2008 Apr;29(4):302-8 [Abstract]
Risa KJ, McAndrew JM, Muder RR. Influenza outbreak management on a locked behavioral health unit. Am J Infect Control 2008 (published online Oct 23) [Abstract]
Rizzo, C, Bella A, Viboud C, et al. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis 2007 May;13(5) (published online Apr 11) [Full text]
Rodewald LE, Orenstein WA, Mason DD, et al. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention. Clin Infect Dis 2006 Mar;42(suppl 3):S104-10 [Abstract]
Rodriguez de Azero M, European Vaccine Manufacturers Influenza Working Group. Trends in seasonal influenza vaccine distribution in the European Union: 2003-4 to 2007-8. Eurosurveill 2008 Oct 23;13(43):4 [Full text]
Ropero-Alvarez AB, Kurtis HJ, Danovaro-Holliday MC, et al. Expansion of seasonal influenza vaccination in the Americas. BMC Public Health 2009 (published online Sep 24) [Abstract]
Rosenberg M, Sparks R, McMahon A, et al. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age. Vaccine 2009 Jul 9;27(32):4278-83 [Abstract]
Ross TM, Mahmood K, Crevar CJ, et al. A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. PLoS ONE 2009 Jun 24;4(6):e6032 [Full text]
Rothberg MB, Bonner AB, Rajab MH, et al. Effects of local variation, specialty, and beliefs on antiviral prescribing for influenza. Clin Infect Dis 2006 Jan 1;42(1):95-9 [Abstract]
Ruben FL. Inactivated influenza virus vaccines in children. Clin Infect Dis 2004 Mar 1;38(5):678-88 [Abstract]
Rubin MS, Nivin B, Ackelsberg J. Effect of timing of amantadine chemoprophylaxis on severity of outbreaks of influenza A in adult long-term care facilities. Clin Infect Dis 2008 Jul 1;47(1):47-52 [Abstract]
Russell CA, Jones TC, Barr IG, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008 Sep 12;26(suppl 4):D31-4 [Full text]
Russell CA, Jones TC, Barr IG, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 2008 Apr 18;320(5874):340-6 [Abstract]
Safdar A, Rodriguez MA, Fayad LE, et al. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma. J Infect Dis 2006 Nov 15;194(10):1394-97 [Abstract]
Saito R, Li D, Suzuki H. Amantadine-resistant influenza A (H3N2) virus in Japan, 2005-2006. (Letter) N Engl J Med 2007 Jan 18;356(3):312-3 [Abstract]
Salgado CD, Giannetta ET, Hayden FG, et al. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 2004 Dec;25(11) [Abstract]
Salomon R, Webster RG. The influenza virus enigma. Cell 2009 Feb 6;136(3):402-10 [Abstract]
Salvatore M, Garcia-Sastre A, Ruchala P, et al. Alpha-defensin inhibits influenza virus replication by cell-mediated mechanism(s). J Infect Dis 2007 Sep 15;196(6):835-43 [Abstract]
Salzberg S. The contents of the syringe. (Commentary) Nature 2008 Jul 10;454(7201):160-1 [Full text]
Sambhara S, Stephenson I. Moving influenza vaccines forward. (Editorial) Expert Rev Vaccines 2009 Apr;8(4):375-77 [Full text]
Sartor C, Tissot-Dupont H, Zandotti C, et al. Use of a mobile cart influenza program for vaccination of hospital employees. Infect Control Hosp Epidemiol 2004 Dec;25(11) [Abstract]
Sasaki A, Gatewood A, Ozonoff A, et al. Evidenced-based tool for triggering school closures during influenza outbreaks, Japan. Emerg Infect Dis 2009 Nov (published online Oct 2) [Full text]
Sasaki S, He XS, Holmes TH, et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS ONE 2008 Aug 20;3(8):e2975 [Full text]
Sasaki S, Jaimes MC, Holmes TH, et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 2007 Jan;81(1):215-28 [Abstract]
Schade CP, Hannah KL. Impact of the 2004 influenza vaccine shortage on repeat immunization rates. Ann Fam Med 2006 Nov/Dec;4(6):541-7 [Abstract]
Schanzer DL, Langley JM, Tam TWS. Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada. Vaccine 2008 Aug 26;26(36):4697-703 [Abstract]
Schirmer P, Holodniy M. Oseltamivir for treatment and prophylaxis of influenza infection. Exp Opin Drug Saf 2009 (published online Apr 9) [Abstract]
Schmidt-Ott R, Schwarz T, Haase R, et al. Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6-9 and 10-13 years. Vaccine 2007 Dec 21;26(21):32-40 [Abstract]
Schmier J, Li S, King JC Jr, et al. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial. Health Aff 2008 (published online Jan 23) [Abstract]
Schoch-Spana M, Fitzgerald J, Kramer BR, et al. Influenza vaccine scarcity 2004-05: implications for biosecurity and public health preparedness. Biosec Bioterr 2005 Sep;3(3):224-34 [Full text]
Schwartz B, Hinman A, Abramson J. Universal influenza vaccination in the United States: are we ready? Report of a meeting. J Infect Dis 2006 Nov 1;194(suppl 2):S147-54 [Abstract]
Seale H, Weston KM, Dwyer DE, et al. The use of oseltamivir during an influenza B outbreak in a chronic care hospital. Influenza Other Resp Viruses 2009 (published online Jan 13) [Abstract]
Sell TK, Nuzzo J, Toner E. Where does H1N1 influenza information come from? an overview of influenza surveillance in the United States. UPMC Center for Biosecurity Issue Brief 2009 Nov 2 [Full text]
Sencer DJ, Millar JD. Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 2006 Jan;12(1) [Full text]
Sendi P, Locher R, Bucheli B, et al. Intranasal influenza vaccine in a working population. Clin Infect Dis 2004 Apr 1;38(7):974-80 [Abstract]
Shafi S, Rashid H, Ali K, et al. Influenza vaccine uptake among British Muslims attending Hajj, 2005 and 2006 (letter). BMJ 2006 Dec 9;333(7580):1220 [Abstract]
Shah SI, Caprio M, Hendricks-Munoz K. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit. Pediatrics 2007 Sep;120(3):e617-21 [Abstract]
Shah SI, Caprio M. Availability of trivalent inactivated influenza vaccine to parents of neonatal intensive care unit patients and its effect on the healthcare worker vaccination rate. Infect Control Hosp Epidemiol 2008;29 (published online Feb 12) [Abstract]
Shaman J, Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. Proc Natl Acad Sci 2009 (published online Feb 9) [Abstract]
Shaw ML, Stone KL, Colangelo CM, et al. Cellular proteins in influenza virus particles. PLoS Pathog 2008 Jun 6;4(6):e1000085 [Full text]
Sheu TG, Deyde VM, Okomo-Adhiambo M, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 2008 Sep;52(9):3284-92 [Abstract]
Shin JY, Song MS, Lee EH, et al. Isolation and characterization of novel H3N1 swine influenza viruses from pigs with respiratory diseases in Korea. J Clin Microbiol 2006 Nov;44(11):3923-7 [Abstract]
Shinall MC Jr, Plosa EJ, Poehling KA. Validity of parental report of influenza vaccination in children 6 to 59 months of age. Pediatrics 2007 Oct;12(4):e783-7 [Abstract]
Shipman A, Clarke G. Cell-culture-based manufacturing: meeting the challenge of 21st century influenza. BioPharm Int 2007 Aug (supp) (published online Aug 2) [Full text]
Shoji Y, Chichester JA, Bi H, et al. Plant expressed HA as a seasonal influenza vaccine candidate. Vaccine 2008 Jun 2;26(23):2930-4 [Abstract]
Shuler CM, Iwamoto M, Bridges CB, et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics 2007 Mar;119(3):e587-95 [Abstract]
Shun-Shin M, Thompson M, Heneghan C, et al. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials. BMJ 2009 (published online Aug 10) [Full text]
Simonsen L, Fukuda K, Schonberger LB, et al. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000 Mar;181(3):831-7 [Full text]
Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007 Oct;7(10):658-666 [Abstract]
Simonson L, Reichert TA, Viboud C, et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005 Feb 14;165(3):265-72 [Abstract]
Sivadon-Tardy V, Orlikowski D, Porcher R, et al. Guillain-Barre syndrome and influenza virus infection. Clin Infect Dis 2008 (published online Nov 24) [Abstract]
Skog L, Hauska H, Linde A. The Russian influenza in Sweden in 1889-90: an example of geographic information system analysis. Eurosurveill 2008 Dec 4;13(49):pii=19056 [Full text]
Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009 Jan 15;199(2):168-79 [Full text]
Skowronski DM, De Serres G. Is routine influenza immunization warranted in early pregnancy? Vaccine 2009 (published online Apr 16) [Abstract]
Skowronski DM, Masaro C, Kwindt TL, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007 Apr 12;25(15):2842-51 [Abstract]
Skowronski DM, Tweed SA, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant. J Infect Dis 2008 Feb 15;197 (4):490-502 [Abstract]
Sloan FA, Berman S, Rosenbaum S, et al. The fragility of the U.S. vaccine supply. N Engl J Med 2004 Dec 2;351(23):2443-7 [Extract]
Smith DJ, Lapedes AS, de Jong JC, et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004 Jul 16:305(5682):371-6 [Abstract]
Smith JR, Wood SC. Travellers need immediate access to Tamiflu when entering areas at risk from avian or seasonal influenza. Travel Med Infect Dis 2007 (published online Oct 31) [Abstract]
Smith PJ, Kennedy AM, Wooten K, et al. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics 2006 Nov;118(5):1287-92 [Abstract]
Smolderen KGE, Vingerhoets AJJM, Croon MA, et al. Personality, psychological stress, and self-reported influenza symptomatology. BMC Public Health 2007;7:339 (published online Nov 23) [Abstract]
Soderstrom H, Jarhult JD, Olsen B, et al. Detection of the antiviral drug oseltamivir in aquatic environments. PLoS ONE 2009 Jun 26;4(6):e6064 [Full text]
Song JH, Nguyen HH, Cuburu N, et al. Sublingual vaccination with influenza virus protects mice against lethal viral infection. Proc Natl Acad Sci 2008 (published online Jan 28) [Abstract]
Song L, Nakaar V, Kavita U, et al. Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs. PLoS ONE 2008 May 21;3(5):e2257 [Abstract]
Spaude KA, Abrutyn E, Kirchner C, et al. Influenza vaccination and risk of mortality among adults hospitalized with community-acquired pneumonia. Arch Intern Med 2007 Jan 8;167(1):53-9 [Abstract]
Srinivasan A, Perl TM. Respiratory protection against influenza. (Editorial) JAMA 2009 (published online Oct 1) [Full text]
Stebbins S, Downs JS, Vukotich CJ Jr. Using nonpharmaceutical interventions to prevent influenza transmission in elementary children: parent and teacher perspectives. J Public Health Manag Pract 2009 Mar-Apr;15(2):112-7 [Abstract]
Stech J, Garn H, Wegmann M, et al. A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin. Nat Med 2005 May 29;11(6):683-9 [Abstract]
Stegemann S, Dahlberg S, Kroger A, et al. Increased susceptibility for superinfection with Streptococcus pneumoniae during influenza virus infection is not caused by TLR7-mediated lymphopenia. PLoS ONE 2009 (published online Mar 17) [Full text]
Stephenson I, Democratis J, Lackenby L, et al. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin Infect Dis 2009;48 (published online Jan 9) [Abstract]
Stoloff GA, Caparros-Wanderley W. Synthetic multi-epitope peptides identified in silico induce protective immunity against multiple influenza serotypes. Eur J Immunol 2007 (published online Aug 2) [Abstract]
Stowe J, Andrews N, Wise L, et al. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol 2009 (published online Jan 12) [Abstract]
Strickler JK, Hawkswort AW, Myers C, et al. Influenza vaccine effectiveness among US military basic trainees, 2005-06 season. Emerg Infect Dis 2007 Apr;13(4) (published online Mar 19) [Full text]
Strikas RA, Kozarsky PE, Reed C, et al. Should health-care providers in the United States have access to influenza vaccines formulated for the Southern Hemisphere. J Travel Med 2008 Nov/Dec;15(6):442-6 [Abstract]
Sugaya N, Mitamura K, Yamazaki M, et al. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis 2007 Jan 15;44(2):197-202 [Full text]
Sugaya N, Takeuchi Y. Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan. Clin Infect Dis 2005 Oct 1;41(7):939-47 [Abstract]
Sugaya T, Tamura D, Yamazaki M, et al. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. Clin Infect Dis 2008;47 (published online Jun 26) [Abstract]
Sui J, Hwang WC, Perez S, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009 (published online Feb 22) [Abstract]
Sun J, Madan R, Karp CL, et al. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nature Med 2009 Mar;15(3):277-84 [Abstract]
Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nature Med 2008 May;14(5):558-64 [Abstract]
Suntarattiwong P, Sian-nork C, Thongtipa P, et al. Influenza-associated hospitalization in urban Thai children. Influenza Other Respir Virus 2007 (published online Nov 16) [Abstract]
Suzuki E, Ichihara K. The course of fever following influenza virus infection in children treated with oseltamivir. J Med Virol 2008 Jun;80(6):1065-71 [Abstract]
Suzuki Y, Taira K, Saito R, et al. Epidemiologic study of influenza infection in Okinawa, Japan, from 2001 to 2007: changing patterns of seasonality and prevalence of amanatdaine-resistant influenza A virus. J Clin Microbiol 2009 Mar 1;47(3):623-9 [Abstract]
Svitek N, Rudd PA, Obojes K, et al. Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 2008 Jun 20;376(1):53-9 [Abstract]
Szilagyi PG, Fairbrother G, Griffin MR, et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch Pediatr Adolesc Med 2008 Oct;162(10):943-51 [Abstract]
Szymczakiewicz-Multanowska A, Groth N, Bugarini R, et al. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture. J Infect Dis 2009 (published online Aug 12) [Abstract]
Takahashi H, Norman SA, Mather EL, et al. Evaluation of the NanoChip 400 system for detection of influenza A and B, respiratory syncytial, and parainfluenza viruses. J Clin Microbiol 2008 May;46(5):1724-7 [Abstract]
Talbot HK, Poehling KA, Williams JV, et al. Influenza in older adults: impact of vaccination of school children. Vaccine 2009 Mar 18;27(13):1923-7 [Abstract]
Talbot TR, Crocker DD, Peters J, et al. Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults. Infect Control Hosp Epidemiol 2005 May;26(5) [Abstract]
Tam CC, O'Brien SJ, Petersen I, et al. Guillain-Barre syndrome and preceding infection with Campylobacter, influenza, and Epstein-Barr virus in the general practice research database. PLoS One 2007 Apr;2(4):e344 [Full text]
Tam CC, O'Brien SJ, Rodrigues LC. Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barre syndrome, England. Emerg Infect Dis 2006 Dec;12(12) (published online Oct 31) [Full text]
Tam DKP, Lee SS, Lee S. Impact of severe acute respiratory syndrome and the perceived avian influenza epidemic on the increased rate of influenza vaccination among nurses in Hong Kong. Infect Control Hosp Epidemiol 2008;29 (published online Jan 18) [Abstract]
Tam JS, Capeding MRZ, Lum LCS, et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Ped Infect Dis J 2007 Jul;26(7):619-28 [Abstract]
Tambyah PA. Update on influenza antivirals. Respirology 2008 Mar;13(s1):S19-21 [Full text]
Tambyah PA. Update on influenza vaccines. Respirology 2008 Mar;13(s1):S41-3 [Full text]
Tamura D, Mitamura K, Yamazaki M, et al. Oseltamivir-resistant influenza A viruses circulating in Japan. J Clin Microbiol 2009 May;47(5):1424-7 [Abstract]
Tang JW, Ngai KL, Wong JC, et al. Emergence of adamantane-resistant influenza A (H3N2) viruses in Hong Kong between 1997 and 2006. J Med Virol 2008 May;80(5):895-901 [Abstract]
Tang JW, Ngai KLK, Chan PKS. Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans. J Med Virol 2008 Nov;80(11):1992-6 [Abstract]
Tang JW, Ngai KLK, Lam WY, et al. Seasonality of influenza A (H3N2): a Hong Kong perspective (1997-2006). PLoS ONE 2008 Jul 23;3(7):e2768 [Full text]
Tang YW, Li H, Wu H, et al. Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine. J Infect Dis 2007 Oct 1;196(7):1021-5 [Abstract]
Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. (Letter) Nature 2005;Oct 6;437(7060):889-93 [Full text]
Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface 2009 Sep 22;9:17 [Full text]
Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006 Nov;12(11) (published online Sep 25) [Full text]
Teo SSS, Ellis JS, Aitken C, et al. Transmission of influenza A in families. Ped Infect Dis J 2007 Jul;26(7):645-7 [Abstract]
Thomas DR, Mason BW, Beer L, et al. Surveillance of influenza immunisation uptake in people aged under 65 years with chronic disease. Vaccine 2006 Nov 30;24(49-50):7027-9 [Abstract]
Thomas PG, Brown SA, Yue W, et al. An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses. Proc Natl Acad Sci 2006 Feb 10;103(8):2764-9 [Abstract]
Thomas Y, Vogel G, Wunderli W, et al. Survival of influenza virus on banknotes. Appl Environ Microbiol 2008 May;74(10):3002-7 [Abstract]
Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis 2006 Nov 1;194(suppl 2):S82-91 [Abstract]
Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004 Sep 15;292(11):1333-40 [Abstract]
Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003 Jan 8;289(2):179-86 [Abstract]
Tompkins SM, Lin Y, Leser GP, et al. Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge. Virology 2007 May 25;362(1):139-50 [Abstract]
Tompkins SM, Lo CH, Tumpey TM, et al. Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci 2004 Jun 8;101(23):8682-6 [Abstract]
Tosh PK, Boyce TG, Poland GA. Flu myths: dispelling the myths associated with live attenuated influenza vaccine. Mayo Clin Proc 2008 Jan;83(1):77-84 [Full text]
Treanor J. Influenza vaccine: outmaneuvering antigenic shift and drift. (Perspective) N Engl J Med 2004 Jan 15;350(3):218-20 [Abstract]
Treanor J. Weathering the influenza vaccine crisis. (Perspective) N Engl J Med 2004 Nov 11;351(20):2037-40 [Full text]
Treanor JD. Influenza--the goal of control. (Editorial) N Engl J Med 2007 Oct 4;357(14):1439-41 [Full text]
Treanor JJ, Schiff GM, Couch RB, et al. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. J Infect Dis 2006 May 1;193(9):1223-8 [Abstract]
Treanor JJ, Schiff GM, Hayden FG, et al. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA 2007 Apr 11;297(14):1577-82 [Abstract]
Trick WE, Das K, Gerard MN, et al. Clinical trial of standing-orders strategies to increase the inpatient influenza vaccination rate. Infect Control Hosp Epidemiol 2008 (published online Dec 1) [Abstract]
Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005 Oct 7;310(5745):77-80 [Abstract]
Ushijima K, Higuchi S, Fujimura A. Survey of compliance with oseltamivir phosphate therapy in Japan. Am J Therapeutics 2009 Jan-Feb;16:1 [Abstract]
Uyeki TM, Prasad R, Vukotich C, et al. Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis 2009 (published online Mar 26) [Abstract]
Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, et al. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 2009 Jan 14;27(3):454-9 [Abstract]
van den Dool C, Bonten MJM, Hak E, et al. The effects of influenza vaccination of health care workers in nursing homes: insights from a mathematical model. PLoS Med 2008 Oct 28;5(10):e200 [Full text]
Van den Dool C, Hak E, Bonten MJM, et al. A model-based assessment of oseltamivir prophylaxis strategies to prevent influenza in nursing homes. Emerg Infect Dis 2009 Oct (published online Sep 8) [Full text]
van den Dool C, Hak E, Wallinga J, et al. Symptoms of influenza virus infection in hospitalized patients. Infect Control Hosp Epidemiol 2008 Apr;29(4):314-9 [Abstract]
van der Sande M, Teunis P, Sabel R. Professional and home-made face masks reduce exposure to respiratory infections among the general population. PLoS ONE 2008 Jul 8;3(7):e2618 [Full text]
van der Vries E, van den Berg B, Schutten M. Fatal oseltamivir-resistant influenza virus infection. (Letter) N Engl J Med 2008 Sep 4;359(10):1074-6 [Full text]
van Duin D, Allore HG, Mohanty S, et al. Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J Infect Dis 2007 Jun 1;195(11):1590-7 [Abstract]
Van Kampen KR, Shi Z, Gao P, et al. Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 2005 Jan 11;23(8):1029-36 [Abstract]
van Nimwegen E. Influenza escapes immunity along neural networks (Perspectives). Science 2006 Dec 22;314(5807):1884-6 [Abstract]
van Riel D, Munster VJ, de Wit E, et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 2007 (published online Aug 23) [Abstract]
van Riet E, Adegnika AA, Retra K, et al. Cellular and humoral responses to influenza in Gabonese children living in rural and semi-urban area. J Infect Dis 2007 Dec 1;196(11):1671-8 [Full text]
van Wissen M, Keller TT, Ronkes B, et al. Influenza infection and risk of acute pulmonary embolism. Thromb J 2007;5:16 (published online Oct 16) [Abstract]
Vardavas R, Breban R, Blower S. Can influenza epidemics be prevented by voluntary vaccination? PLoS Comp Biol 2007 May;3(5):e85 [Full text]
Veljkovic v, Veljkovic N, Muller CP, et al. Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control. BMC Struct Biol 2009 Apr 7;9:21 [Full text]
Verani JR, Irigoyen M, Chen S, et al. Influenza vaccine coverage and missed opportunities among inner-city children aged 6 to 23 Months: 2000-2005. Pediatrics 2007 Mar;119(3):e580-6 [Abstract]
Vesikari T, Fleming DM, Aristegui JF, et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 2006 Dec;118(6):2298-312 [Abstract]
Vesikari T, Karvonen A, Smith HM, et al. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age. Pediatrics 2008 (published online Feb 25) [Abstract]
Viboud C, Alonso WJ, Simonsen L. Influenza in tropical regions. PLoS Med 2006 Apr;3(4) [Full text]
Viboud C, Bjornstad ON, Smith DL, et al. Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 2006 (published online Mar 30) [Abstract]
Viboud C, Miller M. Health benefits of universal influenza vaccination strategy. PLoS Med 2008 Oct 28;5(10):e216 [Full text]
Viboud C. Influenza epidemics in the United States, France and Australia, 1972-1997. Emerg Infect Dis 2004 Jan 10(1):32-9 [Full text]
Vicente D, Cilla G, Montes M, et al. Rapid spread of drug-resistant influenza A viruses in the Basque country, northern Spain, 2000-1 to 2008-9. Eurosurveill 2009 May 21;14(20):pii=19215 [Full text]
Vila-Corcoles A, Rodriguez T, de Diego C, et al. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods. Vaccine 2007 Sep 17;25(37-38):6699-707 [Abstract]
Vlahov D, Coady MH, Ompad DC, et al. Strategies for improving influenza immunization rates among hard-to-reach populations. J Urban Health 2007 Jul;84(4):615-31 [Abstract]
Vogel R, Caillet C, Kusters IC, et al. Emulsion-based adjuvants for influenza vaccines. Expert Rev Vaccines 2009 Apr;8(4):483-92 [Abstract]
Voordouw AC, Sturkenboom MC, Dieleman JP, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 2004 Nov 3;292(17):2089-95 [Full text]
Voordouw BCG, Sturkenboom MCJM, Dieleman JP, et al. Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia. Arch Intern Med 2006 Oct 9;166(18):1980-5 [Abstract]
Vynnycky E, Pitman R, Siddiqui R, et al. Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine 2008 Sep 26;26(41):5328-37 [Abstract]
Wallis DH, Chin JL, Sur DK, et al. Increasing rates of influenza vaccination during pregnancy: a multisite interventional study. J Am Board Fam Med 2006 Jul-Aug;19(4):345-9 [Abstract]
Wallis DH, Chin JL, Sur DKC. Influenza vaccination in pregnancy: current practices in a surburban community. J Am Board Fam Pract 2004 Jul-Aug;17(4):287-91 [Abstract]
Wang CS, Wang ST, Lai CT, et al. Impact of influenza vaccination on major cause-specific mortality. Vaccine 2007 Jan 26;25(7):1196-1203 [Abstract]
Wang CS, Wang ST, Lai CT, et al. Reducing major cause-specific hospitalization rates and shortening hospital stays after influenza vaccination. Clin Infect Dis 2004 Dec 1;39(11):1604-10 [Abstract]
Wang Q, Tian X, Chen X, et al. Structural basis for receptor specificity of influenza B virus hemagglutinin. Proc Natl Acad Sci 2007 (published online Oct 17) [Abstract]
Wang S, Taaffe J, Parker C, et al. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J Virol 2006 Dec;80(23):11628-37 [Abstract]
Wang ST, Lee LT, Chen LS, et al. Economic evaluation of vaccination against influenza in the elderly: an experience from a population-based influenza vaccination program in Taiwan. Vaccine Mar 14;23(16):1973-80 [Abstract]
Wang Z, Daum LT, Vora GJ, et al. Identifying influenza viruses with resequencing microarrays. Emerg Infect Dis 2006 Apr;12(4) [Full text]
Wang Z, Tobler S, Roayaei J, et al. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. JAMA 2009 Mar 4;301(9):945-53 [Full text]
Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009 Oct;9(10):601-10 [Abstract]
Wattanagoon Y, Stepniewska K, Lindegardh N, et al. Pharmacokinetics of high-dose oseltamivir in healthy volunteers. Antimicrob Agents Chemother 2009 Mar;53(3):945-52 [Abstract]
Weber TP, Stilianakis NI. Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. J Infect 2008 (published online Oct 13) [Abstract]
Wee JLK, Scheerlinck JPY, Snibson KJ, et al. Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing. Mucosal Immunol 2008 (published online Sep 24) [Abstract]
Weinstock DM, Zuccotti G. Adamantane resistance in influenza A. (Editorial) JAMA 2006 Feb 22;295(8):934-6 (see also Bright above) [Extract]
Weinstock DM, Zuccotti G. The evolution of influenza resistance and treatment. (Editorial) JAMA 2009;301(10) (published online Mar 2) [Full text]
Weitzel T, Schnabel E, Dieckmann S, et al. Evaluation of a new point-of-care test for influenza A and B virus in travellers. Clin Microbiol Infect 2007 Jul;13(7):665-9 [Abstract]
Whitley RJ, Bartlett J, Hayden FG. Seasonal and pandemic influenza: recommendations for preparedness in the United States. J Infect Dis 2006 Nov 1;194(suppl 2):S155-61 [Abstract]
Whitley RJ, Monto AS. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis 2006 Nov 1;194(suppl 2):S133-8 [Abstract]
Whitley RJ. The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opin Drug Metab Toxicol 2007 Oct;3(5):755-67 [Abstract]
WHO. A description of the process of seasonal and H5N1 influenza vaccine virus selection and development (draft). Nov 19, 2007 [Full text]
WHO. Advice on use of oseltamivir. Mar 17, 2006 [Full text]
WHO. Recommendations for influenza vaccine composition for Northern hemisphere, 2005-2006. Feb 2005 [Full text]
WHO. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Aug 20, 2009 [Full text]
WHO. WHO/ECDC frequently asked questions for oseltamivir resistance. Epidemic and Pandemic Alert Response (EPR). Jan 31, 2008 [Full text]
Wicker S, Rabenau HF, Doerr HW, et al. Influenza vaccination compliance among health care workers in a German university hospital. Infection 2009 (published online Jan 13) [Abstract]
Willis BC, Wortley P. Nurses' attitudes and beliefs about influenza and the influenza vaccine: a summary of focus groups in Alabama and Michigan. Am J Infect Control 2007 Feb;35(1):20-4 [Abstract]
Wolf DG, Rekhtman D, Kerem E, et al. A summer outbreak of influenza A virus infection among young children. Clin Infect Dis 2004 Aug 15;39(4):595-7 [Abstract]
Wolf YI, Viboud C, Holmes EC, et al. Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus. Biol Direct 2006;1:34 (published online Oct 26) [Abstract]
Wong CM, Chan KP, Hedley AJ, et al. Influenza-associated mortality in Hong Kong. Clin Infect Dis 2004 Dec 1;39(11):1611-7 [Abstract]
Wong JP, Christopher ME, Salazar AM, et al. Nucleic acid-based drugs against seasonal and avian influenza viruses. Vaccine 2007 Apr 20;25(16):4175-8 [Abstract]
Wrammert J, Smith K, Miller J, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008 May 29;453(7195):667-71 [Abstract]
Xakellis GC. Predictors of influenza immunization in persons over age 65. J Am Board Fam Pract 2005 Sep-Oct;18(5):426-33 [Abstract]
Yamashita M, Tomozawa T, Kakuta M, et al. CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity. Antimicrob Agents Chemother 2009 Jan;53(1):186-92 [Abstract]
Yang L, Wong CM, Lau EHY, et al. Synchrony of clinical and laboratory surveillance for influenza in Hong Kong. PLoS ONE 2008 Jan 2;3(1):e1399 [Full text]
Yang P, Duan W, Lv M, et al. Review of an influenza surveillance system, Beijing, People's Republic of China. Emerg Infect Dis 2009 Oct;15(10):1603-8 [Full text]
Yassine HM, Al-Natour MQ, Lee CW, et al. Interspecies and intraspecies transmission of triple reassortant H3N2 influenza A viruses. Virol J 2007 Nov 28;4:129 [Full text]
Ye Q, Krug RM, Tao YJ. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 2006 Dec 21;444(7122):1078-82 [Abstract]
Yee SY, Lee JS, Cheong HJ, et al. Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect 2007 Sep;55(3):273-81 [Abstract]
Yoo Y, Sohn JW, Park DW, et al. Clinical evaluation of the SD Bioline influenza virus antigen test for rapid detection of influenza viruses A and B in children and adults during the influenza season. Clin Vaccine Immunol 2007 Aug;14(8):1050-2 [Abstract]
Yoshida R, Igarashi M, Ozaki H, et al. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS ONE 2009 Mar 20;5(3):e1000350 [Abstract]
Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008 (published online Sep 17) [Full text]
Zerr DM, Englund JA, Robertson AS, et al. Hospital-based influenza vaccination of children: an opportunity to prevent subsequent hospitalization. Pediatrics 2008 Feb;121(2):345-8 [Abstract]
Zheng W, Aitken R, Muscatello DJ, et al. Potential for early warning of viral influenza activity in the community by monitoring clinical diagnoses of influenza in hospital emergency departments. BMJ Public Health 2007;7(250) (published online Sep 19) [Abstract]
Zimmerman LA, Bartlett DL, Enger KS, et al. Influenza vaccination coverage: findings from immunization information systems. BMC Pediatrics 2007 Jul 27;7:28 [Full text]
Zimmerman RK, Hoberman A, Nowalk MP, et al. Improving influenza vaccination rates of high-risk inner-city children over 2 intervention years. Ann Fam Med 2006 Nov/Dec;4(6):534-40 [Abstract]
Zimmerman RK, Nowalk MP, Lin CJ, et al. Factorial design for improving influenza vaccination among employees of a large health system. Infect Control Hosp Epidemiol 2009 (published online Jun 2) [Abstract]
Zucotti G, Amendola A, Vigano A, et al. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Vaccine 2007 Sep 17;25(37-38):6692-8 [Abstract]
|
